%PDF-1.3
1 0 obj
<<
/Kids [ 4 0 R 5 0 R 6 0 R 7 0 R 8 0 R 9 0 R 10 0 R ]
/Type /Pages
/Count 7
>>
endobj
2 0 obj
<<
/Producer (Python PDF Library \055 http\072\057\057pybrary\056net\057pyPdf\057)
>>
endobj
3 0 obj
<<
/Type /Catalog
/Pages 1 0 R
>>
endobj
4 0 obj
<<
/Contents 11 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
5 0 obj
<<
/Contents 19 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
6 0 obj
<<
/Contents 20 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
7 0 obj
<<
/Contents 21 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
8 0 obj
<<
/Contents 22 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
9 0 obj
<<
/Contents 23 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
10 0 obj
<<
/Contents 24 0 R
/Parent 1 0 R
/Resources <<
/XObject <<
/FormXob.257654e3dc971ef0d012b196156b070d 12 0 R
/FormXob.ac84e117b0679b7b609587f5218c4125 13 0 R
/FormXob.5fae5878ff745fb447a825f4d49aa676 14 0 R
/FormXob.df788c331935144fa2dec278cfb8953c 15 0 R
>>
/Font <<
/F2 16 0 R
/F3 17 0 R
/F1 18 0 R
>>
/ProcSet [ /Text /ImageC /ImageB /PDF /ImageI ]
>>
/Trans <<
>>
/Rotate 0
/MediaBox [ 0 0 595.27560 841.88980 ]
/Type /Page
>>
endobj
11 0 obj
<<
/Length 13020
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 622.34190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 157.50000 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
0 0 0 RG
n
47.25000 5.35050 m
110.25000 5.35050 l
S
BT
1 0 0 1 0 7.03800 Tm
47.25000 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(IMMUNOLOGY) Tj
/F1 9 Tf
T*
-47.25000 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 315 -0 cm
q
1 0 0 1 0 0 cm
q
q
1 0 0 1 62 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 148 17 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
32 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
37 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
45 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
55 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
76 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
80 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
86 0 4 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
91 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
99 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
102 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
106 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
108 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
114 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
117 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
122 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
126 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
128 0 2 17 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 50.16205 -5.98880 Tm
(21252340068) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 15.54785 Tm
62 0 Td
26.79785 TL
148 0 Td
/F1 9 Tf
10.80000 TL
T*
-210 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 621.34190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 601.76190 cm
q
1 0 0 1 1 -4 cm
q
0.91125 w
0 0 0 RG
n
0 10.77854 m
157.68760 10.77854 l
S
BT
1 0 0 1 0 12.60104 Tm
14.58000 TL
/F2 9.72000 Tf
0 0 0 rg
(LUTEINIZING HORMONE \054 SERUM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 577.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type \072 Serum) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 343.26190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(LUTEINIZING HORMONE) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(11\05629) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(mIU\057mL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 196 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 21.53800 Tm
11.36100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Adult females \050) Tj
(\076 18) Tj
T*
26.38350 0 Td
(years\051\072) Tj
T*
-37.74450 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 168 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
8.24250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Postmenopausal\072) Tj
T*
0.74250 0 Td
(11\0563 \055 9\0568 mIU\057mL) Tj
T*
-8.98500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 140 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
1.48800 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Oral Contraceptives\072) Tj
T*
9.75600 0 Td
(ND \055 8\0560 mIU\057mL) Tj
T*
-11.24400 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 98.50000 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 35.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 35.03800 Tm
3.85950 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Perimenstrual \050\053\057\055 8) Tj
T*
8.13150 0 Td
(days\051\072 ND \055 12\0560) Tj
T*
17.25750 0 Td
(mIU\057mL) Tj
T*
-29.24850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 84 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
14.98350 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Ovulatory cycles\072) Tj
T*
-14.98350 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 56 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
1.23150 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Follicular plase\072 1\0561 \055) Tj
T*
18.00900 0 Td
(11\0566 mIU\057mL) Tj
T*
-19.24050 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 28 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
3.23400 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Mid\055cycle peak\072 17 \055) Tj
T*
19.75950 0 Td
(77 mIU\057mL) Tj
T*
-22.99350 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 -0 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
4.74150 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Luteal Phase \072 ND) Tj
( ) Tj
(\055) Tj
T*
14.49900 0 Td
(14\0567 mIU\057mL) Tj
T*
-19.24050 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
29.37150 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(CLIA) Tj
T*
-29.37150 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 327.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Interpretation) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 312.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Luteinizing Hormone \050LH\051 stimulates ovulation in females and production of testosterone in males\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 296.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Use\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 267.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 22.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Determination is useful in the diagnosis of gonadal\054 pituitary and hypothalamic disorders\054 for the prediction of ovulation and in the) Tj
T*
(evaluation of infertility\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 252.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Increased in\072) Tj
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 236.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Females\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 221.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Elevated concentrations of LH can indicate primary amenorrhea\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 205.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Menopause\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 190.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Premature ovarian failure\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 174.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Polycystic ovarian syndrome\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 159.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hypergonadotropic hypogonadism or ovulation\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 159.26190 cm
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 1 of 7) Tj
T*
ET
Q

endstream
endobj
12 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 20284
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 103
/Width 991
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ:B*7#n!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JF^U(RSrr>5dci*^,r$_QinR)4iCHqRY?gt8!.'1+KRG7DTr27^;!863ZrrAZCBE%j&rY0ipGd%*o[@d?h0DJW!'N+50_s<BZ:R1q[Zb0B>!'XT4rVDlY./qN^?i9_85POGMn?8i?UY0pJf,sRU/,oT^Gd%*o[@d?h0DJECS`7E[o%&<ZeA'sL<)H/ko+.ugjZZcFcLG9>q.i4hl<j%Uq`DcHoB!(R!8jc*_S2tCO(IGq>^snDYPk$O^\RHOJ+(n%iCETcMZ3\>b?=iF^Jb(3Kmcfe*m;bk\GlPnq-X"\`IIL@XT&:XWIMdGm-b\h!7-t;rr@MErr<E&U5D+#R!iuS!%IKRp32Do!9_O.rrBf3rr@`pg"n7Z!1tiUrr#Lh(%k!0HS7)Lj8N!=J*cV=rrCB2Zi:#SV>gN&5I8"(rr>5dci*^,r%%&i./$tUouI!.b5VIphCJU+T.O^TrCd,(IqO#0rd;,Gqt2W;=4J!^m(C7%O82S:rrBC<=8r7a>0m0DQi&92cLG9>q.i4hl<j%aW[OXqH&'unnt.H4!,$P[rd;,Gqt2W;;>m'F^\RHOJ+(n%iEoP]8$_^sY!;#3=8pM8?i9_85POGMn>#kB`IIL@XT&:XWIMe!W1o>ajr[iXb'^DkS`7E[o%&<ZeA's4p32Do!9_O.rrBf3rr@b$;+2PLbW`Q:!0m:dq`DcHoB!(R!8jc*_N4'P(&n9[QF$SkI\m&E$MpKS4dVOaEW6"fo"XmBMZ3\>b?=iF^Jb(3Kcf")/,oUA/SG(]9E#\!721)%0`'i/;rrMqmhPj&c^(p;!.LdE!"(rs]N>+55$H;2qNq+1lA@"`?=ENIr27^;!863ZrrAZCBE%j&rY0ipGd%*o[@d?h0DJW!'N+50_s<BZ:R1q[Zb0B>!'XT4rVDlY./qN^?i9_85POGMn?8i?UY0pJf,sRU/,oT^Gd%*o[@d?h0DJECS`7E[o%&<ZeA'sL<)H/ko+.ugjZZcFcLG9>q.i4hl<j%Uq`DcHoB!(R!8jc*_S2tCO(IGq>^snDYPk$O^\RHOJ+(n%iCETcMZ3\>b?=iF^Jb(3Kmcfe*m;bk\GlPnq-X"\`IIL@XT&:XWIMdGm-b\h!7-t;rr@MErr<E&U5D+#R!iuS!%IKRp32Do!9_O.rrBf3rr@`pg"n7Z!1tiUrr#Lh(%k!0HS7)Lj8N!=J*cV=rrCB2Zi:#SV>gN&5I8"(rr>5dci*^,r%%&i./$tUouI!.b5VIphCJU+T.O^TrCd,(IqO#0rd;,Gqt2W;=4J!^m(C7%O82S:rrBC<=8r7a>0m0DQi&92cLG9>q.i4hl<j%aW[OXqH&'unnt.H4!,$P[rd;,Gqt2W;;>m'F^\RHOJ+(n%iEoP]8$_^sY!;#3=8pM8?i9_85POGMn>#kB`IIL@XT&:XWIMe!W1o>ajr[iXb'^DkS`7E[o%&<ZeA's4p32Do!9_O.rrBf3rr@b$;+2PLbW`Q:!0m:dq`DcHoB!(R!8jc*_N4'P(&n9[QF$SkI\m&E$MpKS4dVOaEW6"fo"XmBMZ3\>b?=iF^Jb(3Kcf")/,oUA/SG(]9E#\!721)%0`'i/;rrMqmhPj&c^(p;!.LdE!"(rs]N>+55$H;2qNq+1lA@"`?=ENIr27^;!863ZrrAZCBE%j&rY0ipGd%*o[@d?h0DJW!'N+50_s<BZ:R1q[Zb0B>!'XT4rVDlY./qN^?i9_85POGMn?8i?UY0pJf,sRU/,oT^Gd%*o[@d?h0DJECS`7E[o%&<ZeA'sL<)H/ko+.ugjZZcFcLG9>q.i4hl<j%Uq`DcHoB!(R!8jc*_S2tCO(IGq>^snDYPk$O^\RHOJ+(n%iCETcMZ3\>b?=iF^Jb(3Kmcfe*m;bk\GlPnq-X"\`IIL@XT&:XWIMdGm-b\h!7-t;rr@MErr<E&U5D+#R!iuS!%IKRp32Do!9_O.rrBf3rr@`pg"n7Z!1tiUrr#Lh(%k!0HS7)Lj8N!=J*cV=rrCB2Zi:#SV>gN&5I8"(rr>5dci*^,r%%&i./$tUouI!.b5VIphCJU+T.O^TrCd,(IqO#0rd;,Gqt2W;=4J!^m(C7%O82S:rrBC<=8r7a>0m0DQi&92cLG9>q.i4hl<j%aW[OXqH&'unnt.H4!,$P[rd;,Gqt2W;;>m'F^\RHOJ+(n%iEoP]8$_^sY!;#3=8pM8?i9_85POGMn>#kB`IIL@XT&:XWIMe!W1o>ajr[iXb'^DkS`7E[o%&<ZeA's4p32Do!9_O.rrBf3rr@b$;+2PLbW`Q:!0m:dq`DcHoB!(R!8jc*_N4'P(&n9[QF$SkI\m&E$MpKS4dVOaEW6"fo"XmBMZ3\>b?=iF^Jb(3Kcf")/,oUA/SG(]9E#\!721)%0`'i/;rrMqmhPj&c^(p;!.LdE!"(rs]N>+55$H;2qNq+1lA@"`?=ENIr27^;!863ZrrAZCBE%j&rY0ipGd%*o[@d?h0DJW!'N+50_s<BZ:R1q[Zb0B>!'XT4rVDlY./qN^?i9_85POGMn?8i?UY0pJf,sRU/,oT^Gd%*o[@d?h0DJECS`7E[o%&<ZeA'sL<)H/ko+.ugjZZcFcLG9>q.i4hl<j%Uq`DcHoB!(R!8jc*_S2tCO(IGq>^snDYPk$O^\RHOJ+(n%iCETcMZ3\>b?=iF^Jb(3Kmcfe*m;bk\GlPnq-X"\`IIL@XT&:XWIMdGm-b\h!7-t;rr@MErr<E&U5D+#R!iuS!%IKRp32Do!9_O.rrBf3rr@`pg"n7Z!1tiUrr#Lh(%k!0HS7)Lj8N!=J*cV=rrCB2Zi:#SV>gN&5I8"(rr>5dci*^,r%%&i./$tUouI!.b5VIphCJU+T.O^TrCd,(IqO#0rd;,Gqt2W;=4J!^m(C7%O82S:rrBC<=8r7a>0m0DQi&92cLG9>q.i4hl<j%aW[OXqH&'unnt.H4!,$P[rd;,Gqt2W;;>m'F^\RHOJ+(n%iEoP]8$_^sY!;#3=8pM8?i9_85POGMn>#kB`IIL@XT&:XWIMe!W1o>ajr[iXb'^DkS`7E[o%&<ZeA's4p32Do!9_O.rrBf3rr@b$;+2PLbW`Q:!0en+MU^Vm.'?5&08M:Z1Z;iBBuVklSrr/(gb<f@571-<>c:*68h6mld9^I8iboZY7U8(@?[XQu9tQg&F)%e^-:W(%4(m0CC?i2k*-cg"^:CPa^C]1)._LRIA&Ddn^uqZ\8P']]a]dEp*>K<?Wqb%.d;A8_^:k3XW\GbI&W<rWOEQ2:5.,T)f<ieO`853pER+nM@Q5ca(`l3-:?u@/,aI*1d\=9PplFB'e4#2D;p6oVLY1Him[2ghIQ]1S]Aic&_ii%MV0XAT6+LGn0)5+T*""]mEVhcQei,"YB`(r*bFl;PRZ'Jal,-,62P-9\Y'mRDLILa1KAm36L;N\,YpYq'+u0_%hW,.p\ecWnh6o9+Y$TH6(PXU93;!)r82SaZQPoAH,Ia=^@+75dUGDW5?@mTFB=>:#,ShR:$j10'h2Z_CM9^HWQSL)Eb?M"fFVW!@nMA$Z6NjNk!g<[eCedM$OchH>+SDk-;oEuWNM].ChVKG\9og`f(@s::2M'!0T/%(X27bYYY&co!St4k8;W?/!NoEU3i`D<%PA1:INJ&8knXc"m>O`buiS/ID<4ka)LBtC@c@(ptBY(Uii?\59WN/I/et+eHDtJD$;V(Sj]pScnfYNb71:YXfM;]P5\p&s?1#D9']e(C0<&5q^=)h^%a$AOI/nA%hSX[(.Gsu@Z]&oRC)\9CAQNDCjPV'8F(j-Z[;-GhF1t/c<.&)7r'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!(!67&`E-4Ce*Jp'A@^65)18q,6\ScT/:Ddge+B`rC&T>kRY@MO&S]sqV"02(/UgcS*iC7aJb[adCL]e-[<nJ;(!l3;2:+HIFLKn_pe->\]VIm\#H>N!nZ,$q\jL-?XsN@)V]tPCO;!XoaQoI5G=;!of<MGHEo6AkHn93/[/SQN12XWu`nCe$J5.d/,O+'kHpR9Pa$T<-[Z9XM!M?dD6Y7R%J,gSPO3X(I.8lXYZ/*f4m\/[%%r$31QT&")<ph[f.&bAVVnUM5#M-7=SUX;`oY[W[?)3dd89[9N_E.,28p<\58Lq/^;-^N,`(pbIl:GCgW2=8N@M4V3S'Wl,XEXH?V*j7sNA>Me`Y9Zb3ukMi&.7gF:;$I%k$?,/VYV?d797+:\'t!FYHD5D]I7<6_)P<L!iT@KUI_f^r*&15-$8rLPa>l"mch_I:?[BIp,4>#*G<AQ*eEA]6M)OeY5%$F0'.M##6X9dS&X;+K0k2nI76SXdWnD,7O5`2@i69r(IR8Lp,WO0W9WTLKG@pW7r_;$85Vei!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z_'MlA87>O/5-k/.;BR2HkL8?OW)Q]82]<?:uUVj6tS$G%)'DG]lPfT4UIBfd*'gg$15ctKU>denTnlCSc_7#T2+:jF9mPNH>3Ed*#G%<S&2`#fEP([kpZW.@'D&d[N1&YDBT^bh:;h'o7;*Bb.Xpr?BVe+@FX5K"/ud9PM#&r95UFX&";"8r8nW8Z:qgZ%>?P&=OW/tO@k35B?jB]]Im[<&^LZZWs.:@RY.hWf0L?nNZ5Yd_hB+CG^i8Z:tODO#WYAU-M,4o:W6QXMu.&3>B_hAp=d&>J%&e"XCT>K=Gtd5;-5]t`<@R.D%;BA&nT#8MPl'PPkMl.1oASp$j%X[!#G!U+UOBASQ?nk66k72/ZG.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!/'kpbrrC,pJ*ZAalX#3??.iCr&:#)#Yh[3ZhH\H`>l*C,P.Io?jiKA4`u/IXjp>q,YB>83<7QHA<_-Z0QSGO`kukGqG1V3a[@afl*55F)3X8JH4(B/kfUDH:z*JHbE2MlbSWG;RkaLbbu(_SUo_/?&f5:W6nd'[%\hmJM'T'K2!r\7_al_ZWnVm9=.RW\S]`nZ)j%ZUH^B5$g0Wlac8lTb^A2_c#Uo#:fn[-)AZTDRhRXC#\M3h/Meq`B/'_8ocS%KZ5?WGV$qZaWIWToKsd@:P9`Wr2poaf/V&-+:B<\FQg5pm8h*?3&G*n">Qtl8]Sca?gqX2ZEcjNrHdg4fY*NpDS7pD-C_GAdoU46AF@VmaOjhQsZ'j5[L([/(MXrV$m;'[uE;i?=uHHJTp;/Fu,SMqb+0D,?2F`\%5R";)CT.IC%@^7q.a.WAe\?,IZ(.(@W*Ff3TS_93[rY8@j]"`j*_u:q7a9^DQ"fY3917RS@ts7+AUP*FDQi2;2>*aq1`h!-/pTo^0sM=/dd*Rb<+GD'0U`G521oZQ>T^<-B0TSY_)W()GJprqDThVXLYk*/mY(C#'gjV/*A]FnA3]NFp48e"sTWij*oM[kNOa-]UJ1,<>5W>ofR8PqO*V!8'J"r=kOR>Nf6bXl6q%dk'Ig3R#mdWnd:.%+O<5Z<Na"7A[McFk\IA0tKZ0@?**4#C7($9"\AF/t]-(\eU4'p^=#pp3?Mg&nbi,1.ZcpT3qg]`"GQFK7!]G-<RGoo%FnN8[fckPNEJ+U>te?f<(p<@3(309,hHK+G4R:.#d>mbD]LGikGe72nGTMH_eWY:MFAXO8CR"8:^C:!&9ucdZ];S\5lM!^"`Gj49ZF#)YUA9c)k]HRYC%"H[S&k8C_t24SjPk9B5DVo_ihuZ&EDjcZ!D>;8%n3(AqS-oI'Pbn@sSDm/1&d+MYD7FRUD,a(M:P\"9\S!.J82Q.k,0[Q9p&/,M:YUJnZRd>%_uo1^Rl@OF.8Qe`]ei#@Stnc&TFi-e$I?Kr6qjtV\2_#rgLUPs?9[7g"a=jcS`4[,9`E=?$&gs""GX7P]a$ZV2o%Ja)&VO:j5b]bLICpV-Q>]PXb18dj>iui\JCSPU#Ib3n`=pr?ql,5*bkHE-hd%J`XZt,V@H[Z,O$Yh^DVkXRr59*PQM&CJ*&!R0?q/AJ_Xh'8<db;\A"f8k4n:F2k,RU39]F(+0Cid^qmXg<EVBDUj-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-j.`n,:i"b-1KfK?7@/*ZBV3%7F&\>_>\qGX]s,.H6Ag!gIPr,Y--kc&DQ7\;q6^L\#8f"`^nN[g,TaN(h&\a5p#$b=_N+VRkmcKVHMYE_Zf"Q:m("(.W"RIWgm<lP1]Ac,6%X<d!d;9V7]AV0Ze96m:EdL.>sbu52/U*#-p)XhsgB\2jU^*>#ihhHSm=\(#RLO9Pkl,[<iAVPG`/H"oX._f$Ctk`36Z7O]&lXUm?L?HWV3<BO;pX"Yo8NVC?O%m?[J5p`<5jb:@@HK3ApU"DG^>cad!W\X+T)e<4T7`cKku^CgAkW*^6rbXEY;=!'&67mEBE7@R#U\?eh"XKA;,NuK6ePbR38'T<GtH`#H\:olV,G5!^?b,!F?!;_Z%asC25oDDBGnJ@&AQc7Mk[MO6rSSp*@S=6k1\<)q#r2GhZ**5/ZkE>#DhDNbuY"Z=L1JFdWCWRVek1eW5*^/iAVpP(*R,F!Q1<rk.(kl9"+u/;V*)t><=i5G0gfBL_b_d.t=MT(^Yrtf$Xg+nR;6i]^k[#Y+FC#XMorPDcGBfu1>?Khp.S\9u5.N]JVVU-D\gPLE]8]]ZXf\GKe0E+";L&3A"($ZsM5<LcDkYWs,J,4b3l7T]HLm*EYI'9J;eXna_UdtHqhAdLb5F(Dj`VHINSaN"hD/"gJi/)jhHJ1Fa*oP^26RVV=$HpHh'rf>QMEp8867+4g>&"d*=(RSg].@?!!!3X=ioXi'dK/)dOYGn6'6WAQuY2))!6ZDYu@Tq[9[ZqpPFTW4smPH[.,+s:9u"5JVDl`Toq4YAFL+:>-Xdr_b.Q1,%#T'b0b(Wpq[hP?1H.SD@WXuNieN3I[/esko+H8Oeq`)Xie]Y"OS`:qIFSAP>&3Hbq.q\[X2,t.18P?(EG3>^n[1MIaTht1g#a&j&SJR&.7IGSOF9*!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!#%rbl!9@84J*YNir<1`1_09nX%1C(F.BuWc/>oe@@tNBD)*a,ld;.TLN@'X[OVQnq<L&;)#I,"@oSkV!..!R$Zti4XjFO"&ML@hO"0)4`AK.+;WhQTBj]VkLrJBRl#hldPHg/sQ3B^&r*KGV3IMGpdfAtIjnOuFD:XUJF=X3eVg4m,L@E(q]k8chJorhqR)bD\-]R*aal8@:Z(r:>9J\$EW6?J2Dhja58g7,r5B/)%<R/>O^:+CNGZ7F\1h66,,O6Uq4pO<Z8(*K"j0]0h`Rne,d"I21G,P/('Y+W)qk9ntp=ME1\UiC<4hSb?Rn%l0cF?LdT=;OW8&L<r_TXRXhrrB\93r@F93b=$,bVqI=<qB)fbYlP"Ajb1%H;ip5lR/O@r[/<JROKNO.^C4+*SbJl%YG0Gq2tL(2i;uKVJEn*n5&ahdTik45eEp:(231nlc16Z($bD,%Fbml`(;LT0^0d9<ZZo4V[eEU^p&X%X!A6:GdbD_b@?Krj+G/.H3tWr@YIerP?VDa4KDi"[*eR8&S`43M!Un-TD^Q?^:2q\\/^/LmfS_,5Jk#o%h\$7CZ26MMb#&C0;/nkVV`^UGkkPc-p>,DNpB'\Dm!.'mnC'ZFiG\m"_Qem,ZT[PX_,(ti`g)&BQN9+a9s>@m6*tu6An,ZO_H<Zd7"d^!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!DJYYiEamQW4BoMi)Asf4u,Xjpbpt\gNVPn\b*sXW2mN2kRT4aa6#I`VtZS:IWY("1-/Kll[$7o*tC0C$#6[D!#%L=iC&(n!3Usu?*$5?Jb1.uNEa?4X?)r:iOo<Le[5dC5s*D9>K_j'oNk,KWRG7!'NZ[@58.cMNiT/CHJPq?C79-?mqbRQ<,RXNaR/fQ5!.<_[T`HA89-S)=R6M-4G\KI6g;U??V6nkHNDa=1fFHbOW4IT<Ir+Q]\DBKWn:GKK$>:HgZjqiXPHED#(K8;RO#FLJ;S-0/b/!u*-pe^_WUNi!=Su3&:"C[NG1<)08M2;cP?5f>[8n)VV3H7EZm\;!il8#^&!.mCIm'a]aNf][<(;R]8OYWj=[E\NJNKH_?%Kg+0AJ>fFLZM]_QqfYNamTT>\=kNIop,$r(;ODU%<"59DmG!$2EdC*W7MMDS%'87*$6l)eNsa<F-[hAY5)(_+"Hf=.IO=!IgoBWautnNH<8YBZYYB]'J::)3ng6#;.%DL(L$(!f+_9jrJkBg*\E>;s7-^AC"1&V:bQj5p*B&'?mXdE',ql=@3@">;UWZ,IWIGB8;-E_/EJE>j%X]LQ\r]3c*7pA/sUqf\Fam.^MGW+35nFl?,79#842?\uEkiNEi.3dmTk1^KhIgMDS^m^i`W%o*/N57/,`#H?J56$EB+D)?<#j!uBk)-D4tesb4!W5Vs&'jtuHO9-r'pi6<6,kFJ)!3RF@0s<7>rr@^[pqOdTn;um9f?aDl-^&>AFp^/dF0q!CC):`1"5J@_BD/:kIb+hY,[KXNQo?esJ^fa,Z!M&W<j;L$nB?&Q1fgZP\!7nbQ!?3JcT/s9rr<@dMRA95>uO"pdmfIsaRS9R\X)8`b8%k/j/.6OdE1#O8><UEhhX)7U$*,&[Sac8Xt`HlSWB*L;hchm#lsg$g/!S`]71FJG^%([=W>b'DQW=XpN^d-lpGic^QgE@#B*%M4pUU:MYpNrY+\"MR0K"h8EY!-b`IeATZI09ZlG]An#Bq?=(VReH#/L<Xs"2`$C;X0X23Xg#UbWp?iL*4=CQa.redX"/5OO&)gK]blWZD_M#9^"rr@c,:"7b2=f0\;]J3\@0D9Qi+E[f,WQ'8s`G"LZ"4ue#b8_)+dn$a^MHSc\!eJjbfN05AWqa>)cp[VjkVi0U>[Y`+m#YGi=!4qH=gO72[:*6`^@0!((\)p-le'N8NLZJUXESqfX!;]kdhO>Al3F0%E=LD(4hSlf/i&SZ_3KeS,HXOD?1@jo`0^=SSr'0)d6Q:6<iXl=e>US&P&VCJO-oOb5G^s2T,i0/_tQ*2]UAt">KsE(*bKbeP9=c'Kuc:8EDP9"fFL]T/h_'XbX1IS(eh(F0dDD/hLdse[;`i,n\tHuXejZP9;^?3HY+o0f;WZ@al*H\rjh^'^E-]r'59W?]UCoRYM2p6_HP)c-Z6b&p,mitkZ$<E_"ClAP/dh;/;ShH!ll;4(SUVf?V_WaiP,rAVtlBhp8B:Ch7"9A%cblbbMKT)10ZX(JYUr"lndq37N9fs\BjJ46f(Cck`797-tsr+"Q1%Tk+>s!YNtpaSdi*SojV!+d^<asSQi1PL>)Y&*WH*\p"t#3`&cJ3H*Yl]6F!m/q1=#aAh>NSPuM(7a'O(LDOUa8U:g$q,2G2qMa%eBAI@:!c7QK:+"B5)=)m]<N8rft5=!hJ6$M?0;bk'<ZatK&&Fm_M2FB"""E%_4%lj4M99Feh'N^Z+r'8hM]M#'RC,9OEa/D`UHYWp*jg?@a2`=:":Hq3M'6p:k=2$WDr'-r[Bne]&.K'()j(blO6,DWFGj3Y;B#*m!U5FI..&)5!.&)5!.&)5!.&)5!.&)5!69k[;J3&m!=2[<@:#W3(iYsC`d<s<BO^09Ip`mu?L1A"Y#Ie\T4u`!8cG/l%Y&*J_.qk+.,eapY@V1O4/3rX6gWaFND;"Xce02>Vi"HOHa9Mr["-:TpdRLC<cCs"\WB?fLGa4QfK;Er\nDrF8o@CqO^<:[jIkF'-a3E.hi(p6cZ)D=jkhd2(3ATGt>t]FkaWoTa^Dn4CqC'YkS#("qHG)_U0Kd>iSi2gU5iAmE.\DM\fK;0nSNh>QI`jC,\$#\-DE[St!A+'NVh2"X%3_n'`E&/'[o/4]O6.RO-fr??J_q`"dY0km5)tdoM0DMUMpj4r.7jMMOcN]::Pq2*?2/<l`0/s5)5M%eQH!:e`OKqTqO^s?poCAeD5(^tElg@.Ir_gLGoqIp!+e[P1b*^WT&=o?2_\KLadP4Jp"83_nu6EJ4<5c(V0LQQ+8A<DZn4W(h1`V73H^a9S;d.$oWGgGhBRL\kfU>k-.OYR>?O=b>"7Orct>S0XX=X*a:<nNMFV2K;42n(WrbfBM'n0#H*X/WVWIt<jaR`HZf1?lpl<AVlctY4BO5DCn5t[oF6Sj'Sak7Lc\h,PnNQY@.am]8o]-)U>dr$,i^Q02<GIf\CZl#9ZRRD9?ka$4:BI4+er2j1:_J!Q81?0.@)(1P[(&j"9c8s[c8)2'MXl0s_>4jq&bI(W7'cAi'DC24=W+ZfU_O+^N03soLdasU4_*m1@,Tj,TDIb$@d4VP@C$j-Sh]P;61G?!^)jRc5>KXKrL1a,G-T'(7q/Nh]3q.=OnkVAoIgd/[D.8M$S,2%%!E'gC7qmk'*F9WRu5Y?E&JL*e^uA,_TYaT&ctcYQZgb:8M22V*EAU3?6u8bUA00/$a!pTpXY&ZM-!T@;?rcB0hh'l1XBLXY'>ju'Dt,c-.V140=?U9+>FR?&h8^Wo=McaB;)@!9(ob9`,8sbKWR(?2W-T(KD<h7bS)neViB=;iER%&9<Q""Y5CHPZ-fqJ\TG*V7V8u[)'i0#_le(KE(M'?9%*2bkaI!ZVpcI"2``:cf#<itR)gP6+J/OV+-EA`l#8dDMC>QV.&)S!.&)S!.&)S!.&)S!.&)S!.'2f_=,0)gYB=!t[!'h5g,LX1&&dC-SE[d%F[j*n-,#d9RaY3'+uZli`d;"k!-GYE&&03O>[ZWqJG"4=cA.;T>H2J1,1AAq>qK,NPQ<qen2B4`E!a]-Fl3ZM;+tnb(XdOE9@WA$pg7+PDLTV?,`rq*&drj-3#lSG>(4a^H:8S3pAQE/?&+CrNt6#LqH7%@GAE+%kAUFj2\CWIkC]:^Z_I64;:K\@'OK$!Ya7tl\;C9D^bA3uh9RJ#(o6E#3sk@m/S'StMjRq9G1dMLiCo6pT_1NAT"MZ'`%S/qGR%*[e#[/l^:`Qq+87.%),H`Se#n!sp$l+@oe..t=rrf;VO6]rO8U9_GRB+E%M(+;@fq@PIa*H-<*'B=j.!)r?PGr1`GV$r,;Ua)8u/_Sqm1lGjSSZdQ)X*GcEX8AG>#QX)K`Q]]U-,!=osYKl3hH6P!LVJrrDno<7i7Z-\\?NM.8:Oi=%O<<0cCGa.pmhV;/8,A[JhoY/S)OTULdaWcqru*KETZ@tS&`n\23#pc@@]o'Wn)*EBJG0.m?P?k,TN\"$q1lW!+4J9lna_Em1`AhO@(>.iHj-2a'C^><'0Ak(gBl:sYCCFXfSGdC,l[%@tG<Z5Z!Y5G,^.(B#p(h\=G!$7eS_#X>]Wbm=P'NYh**tmn.2<9[0F.l^i7h;&OC(i=bi:E45?:H[<e5h"\`*Gn4&7#ZMZE^kt(\_Cq809*f(/qU$@jQBFELKLiRS45_VFrIZ6M!nq`tW8kh9H(QaX$Qp`+beinJ/6fi:-2k@+0qF[qY6jZJY4_5:^X;pJ5^"^qB2EMEFVl:Cq8a<]Ya($H#$:NL>L<-Gg1ArSB?#HP&tNG6?<D[<1fEc1_$O[mq4sc!3kjg#qMq.ckpbS^^JLIgr09`n'(m0#`ub@aT3V>S&^acTtb60CbZj1`O'iNa2kChUI/m^!*SP(IJ2`.Zq)ZNdV@$B('78UX<=)\)U-Vm6!(kCfZX&CT&4IGY*bnZ!.G9A=_?fNG%97EXr\*[oU#L[^j$!/f"_U37$9f+\>V'a#PNN*)]bj<s-sNY;RFXnP,#C!/I_">:h^S]k0go=PtfCLqYQFPE,IScQ%;^bHDV)QWWc1X/1&Ehb=^I>?6#fGFpWXT9XTlkXRh$HSu+U7<@;nnMp&OLXuEsnh)/LTX]n?#pSCPHXML$ejcRs?P),i[e%E9(kYUcY_co$\A$a"/--*OI_X1+Ol!lt'NYU@Ge[V7[(R7'9e+j]&SeV=Q5>XMA&79P%WTQLbtFi,UK`Aho([.AG4o9Z2TFn9ilnlu,*&=Nj;u($5"BC>gJM9J^C\%crXs\oM_-&cp9u)Bl2/:BUNg%BaT-_(EdHo+g9pI#LuIl)Mef=r==0ZB,<`V)=N^sX\-FC5EK&gSFJOHZ)CV>d!2>?!!2>?!!2>?!!2>?!!3T\LIN,ri5)F2hAL%l0*Sb_"1CuIIF3ktRY+i/u=5o-F$#'K=]7sHu19=\h`c=@.rfp?ooE1ZZO7;j=(e8FaVoo2]KKg\<`.a@<\0M,r%o,3T[B=aQ<Gbr7f<cL/=S5l[J$V7]6&\^=4\$XfrrD@cNVADhgHPlqM@jEkad!\m@s?/5E-'eJcdK:tSK?T7,Utj0q2R1uY%]-d)5VRR?F#JoeYUctJ)M[&cmhU*+!M,Acn[A'E_#<Lm/@1;2=#$,r)7APTrQ"JYff.L8K+iO-NQaY8aTea7i[P'EX-o^FpFN#4p@"`<dOJ>o%Dc'rqP/P#p#>g&jB.NL'[tm`;?"gr#9^W?MI/g\^ke>V2o_OTMe''BcmG/N-;>#0tB"s`[#S[S<'LU%hbl3_=5e(:>odX^U.q>mpg7jI^u?:jgZ;k4qdB]LNT*LnA_0"IqIT\As++o@UX;&/$sBnNo+$DC%1ju\+&",[)jt<B"6Bho-'NiL.:Okra#p)c$DSHhm7:Xf,<_Tf>Phg3,]7SPjVa/[JckM+*\7,EUVL9eE"EGW;'$_?be@?G3X&eZ.h\hSJ^,t6j&RAA7U%,=O;:c`;7KOV*Bh*o_,T=S4aQ>6+9VL(b`B-FRAO&(Q&&`Sf:rmNN'GbD<b:58[i,Er7qj/FKOKD`._Si3&j&MF%IK6$2bt+4)YgK(KsS-@ht]<A*j^TZ'm9N3rg,D-Np%>33'%KpJr=8dI\Nf=ad<n:`!"npXiPgS--5\q1iBbOhGu*gc&_&cSXoMUB?h3]JXt[nInC^"EM:0/?Ruj6tSVk/?B$[0oq]E,.XZM#NC_$_cY9-SP)aQ')Tpq1C*N8EoUd7!$2/'nWF*$Y1$_I/[g4MVF,>3Z8SCq/`S:@Q&g!XeZr=W'$L=r8NeKaP!EN%91ZS>Hn2,ZG>AmuD'$`2M(27liufEBPs`E[)naP*NtG[R9*<56?CQa=9M&51NZ0*KniCBoJ3a0fOF,Og\)N59D-KK7(>aQ7SE:D-aakKfc7j=kg6-=1bRFGo_g8]h2psfUV+k\'Nu<Q/.tYYnPK@&3c3`h(=RY1_'PTp6dsO<Wl-#je;ETmjQ+YjlisZ_+#EG5Er+j]JeT&-MahZ$a9:SpZBFY[T!9*R4BR1@R/b6l[BT-9O=kD`!PElU]E!c0]9;D8`>*m/D4sBG2eXPh5C2I@5bVtk,T&d@@lhT.JOF)j"e](UA%o@=;40T]cL3.4W#Q-cK`pWQK)k1r<:UG^W.*3`h3<5-r1W<\i7Gb.pi@?FLBuAfK)2j1$]ltKp(`:?1kUW<:=&P'PQ%fPh+P/%IO7]KF)LoUYD]I21.:k:`*`uuO`-'BCa4?5]I/lAciJZM.`?$;SmUWeOFZGUU(,dJ'!r:Z6!;j[-2(+E32gOD"4&38jOpKq!:l=M]bWmYOJHGoDo*VV"r'?*5f<2K:FBqZ<HXN^<CD_!m%$(!mqo74@IYhQaEMi"&iq80p@Nd(-_`7jA*":<jY*]cFkJHum+Z`WKSL(%*Vq`/=cZfbN?ubqF%nq:n232V4Ih9MAYK6HA>=YbsR&!j7cp]S8WYAk=K0=PX=$bg6)qaJc2g04G?"qp!M<7HLGafNtpV*1_3ll5sg/oqG\n7np;T\$k6p^^Q\Bh<B?YXAIBj`(2HipBnDWaL(d]P-amPmYLW=(eDXr$uX6K`=^+8pKuHoBS[cW\cFmn<O(oZoST4D\n;Or,D`E4H&rB>:Vj[_LhX1W.pP^%BPC+)52ld9DUV0g.FU`-u0qpj^="HL@abQS"KbSZ!f_BXbWKV:3q?dEOhiaM76-Ml5#\l[8JVnRAm;9l"q\1h"E*dBT5%!;,MUPMsdb[Y*PP4r`7%+&15gjhj)i>\>?Z!.PF;n?&6?i]`:%Ga]Wh:Ks6Y:rR;\HXf-'-Q2";oWGolPbXuUQ^>U6O7=\1&W%Y-*-un<-s6;7pCj',)!BJ:`kEG*nK#?/*Lr37[+&QrPKmVmM@Mne4S)iA'g0e9"4+W*nEKjFWn?UJCmOQs7-Z/kR=`M1jE(Xh+4o5BeU/C=^Q'p(brU85ik'nR@s]);[D2ld6_QVTW8uQW75[$.*\X[1>*"A"#A`:FgUfRRl8rj[j@!M6\;Ak!P[rs9oVqI3mU&r)n7l0@;6H[*+a_HFQ4TUb"j_ZlEVG6jHI^Q:Xn2f*]4c(+4_'l^WVd2oA#3nn?t!JPCM4[U#U*=Aot[U$RVE(ra7/iAl_eG&ZY5G*Bbr3M]#9UEj(ZVL>8b`hT^I6/XjMMVIAckp?.SEh[qIW%Kk"6<M^_'pj:REc0MQ[H<4TFB.H,,6<kn/@LskSR4.S:diFB6>ciBsKEb>J"E"?8jX/&`p(f^QK3!0l&/_tqS7218#U5Aq!U5Aq!U5Aq!U5ArGXD'S]mZfu*I#RdJJ/qXIPCa)$H\#0Z6)JBU\c^XLg54;He1[(9)hA+d:U0R-ZUH_)"+nsK,HkGKQHNJ%7F%KSZ^$68V1Pq11$[pEF49\#0j4@VL&?G!pmTB/qbN!#Q3KWk\X3i.rSb5LO$d6C7:3EG\.oW,flWL:icL(RT\AtP18uF'=[R?;Odbm`]Fj/jC++1`HWAPP8<.+(dm0ue/q?%hi"+H2`HlYA0q43=H2dl)HnXL*&u00L'55d,lI!7;.?S0F7sla&c@61n;t-Bhi]dk+_lMWr6*4;F$10+H<\Y!m!s[q[rr@gXmV&Nc)Ft>O9(9$?DgY]'iXZa[=>Z<uR-h$B<OUt?$Sc$"J*#+i*IkqP+,S7Qegu9uD>/<_]l`#@)>g4BT^,f];KH^1%lr'%'PV_3.b$+_['sm,O=c\I4Jh'aE;RA[4jW(aGaI@nMfkkPr'+\0Bm]!A1/2aC?(]%r[m,Rm>np\sGJ1egV!1o`-C545Vo.TL_@FZ](</onP"Fq5@/+*H2nEn?Y%r?bQL\AI'+ZWZbec>0h-?%%l.`GFY)86PYF$<2IN#nli[gZG^6[R._/878`/M[bT=iF1!'I_WHIkH^>0D8igfm'e-)@id<@<`Qd?Dq7[7(R"J`a7_1WB4Te$T,T&o*k_RSAaa.;NnBCP'2Om#2D\anP7-HHqN1FOdRkd.N;G/?`"`-N='hD2p@J]qGA>Y?L>WWqMA]&e>+[g+S(p1sH,+q`XnJVKR/g7<$3+X,]_Xc_X:-G["Ek't9%496Y"BM$M_lK#q6?7IE`bF4^$L?*tAn7KGpl;ufca'ED!!'ED!!'ED!!'ED!!'EOi/Be\ka*Ti]-`F?B:TjcJIA,%#^ij:?DpnGXk9sqR)6X;aheG7Hpk2LM\J??A$5+q*)?Ah6MRnCJ:H4P``FM2b7(UM;&d;%+1^_)s!!&45S#!VP@R_Y!C`h^<PYgWdKZs(29Gh7-1-K^50i]oL(rgg[QV9r)m8.R)2*I0gupg-`->Znb`__>3ZeV%q@;r+u0kP8-,i-uGDc*,c6R[0P67^")$1WkYg7W<C@!It\So>`i:($Lf`gIlT.ba-VgnH'r#O;:O__<NLrVcE?kcXZGkW4Ho"D2e18oLk6'jR6nEa?M&qank#*]KbAubpUKE,h6Oj#(oj!RMA:<PTX@XA,nZNK\''i9:K=6kDLmurr<f37FNj\>t$AHq#l#FG3uh.ENihQN\e[0lD)qAh\t_1@o1VHm5i>FrInd6k/ok+80)[(4\556Rd.!HSNBSl*m7?e[Wt(65mj<(Xp6h)S#Ng,!TDTjI[PMj)E"t6iZ-]XXHkd3VLQX]QHik7^h!*t*7oZnKXEs)_iJH*C,YY?9m"ugEbZ-i9?(n_(_=1g*=$?GW1m92"3I_D,CQ819?$b)TPS&*qU?q#e's0u$f@IpJ&g-(:[j^-HqiR,&*_^"NK<u^_AFm3<FKjiYRq`n0Je[NTEj2a>'M7%L#JUKQ7!M[O[CW064[7%U5fMB-t?B>71+j'!C5iK*<eZBlj!]nGUlpH)IMd\(E.ALl7ji-pMlOcdfX;=%YXTA3W3VWnFKqH_Ko7@-.\[Fg"N+0NPda3%SLm6rTpfLVnID)'YU;mj`M(C?=!IudQBl:YR=)cBd&TVO-iQF!s9C\bWFE6(P)E^Vs0YZLU><):JDJnc"Ps&D`N"ph!'>"!1nGW"$BY_d7I;N%mOD'C1>B&O;[FEBThhp4516#53L,8:AChjT+?(D[8.>Z2`bU(F`qCV;b##Q(.[.d0oYYSV0ZtmrM4u6D\5@8`1@h8Y,--6/_uXC+W"t<AMdh=+D*TBhugapF&qq!^[XgLr'fPuCL%_3TLf!mNBNctbf,,UO:G"j?Y]7,m4uRX5aV1&f4_i5Ga:TZ0i#*\Zd[n(Coq*RM`KH!@2JJL?Iqo%jRp7nl5GqKKcl+cASiXR$#U-W!5SX?DASMW)9#Xhn?7[*Y7bSrYD$mOohAM%\VBc]pMMeY.8Y*8Spbt;HUU9"^u=X-+0Bd3_=201*n=YV;/;kFGB5lnQ<aCX"qE[IjkDV\YD)m?BB#ta&9q[P^eK4i`H;@LYX2:h)+s(`3e'9DF%%.thV`?srX%0DoR.p,f$\IJl'!soge=?OElTI9#'Tn(5LOBb_Re6g,b)`$,J1:/rrBBpCNqDJGu:R+8T%,cq>O[-'RN>c!Tu34#?>,bGMX,p(4U4nIkbKjhH1h6^F*oF.IG]o[1<UO?#0ES^Q)N<(6FK]L1]5o5X&L7l/*6.;+J!T"Vag1!C[]!!C[]!!C[]!!C[]!!FC9GJO=ZSd9$IJ;1oL-rTa"^cdjpI4'o9e>u';'Kd9f$GI$1_6^8egWf+2W%i4]b'DOK'=7G.-gIB^6/p-Xo6nTKQV`h7KQ`7-g`@5;tCV!9&g1:&^lIZD3[$R@QZ7kst3A&)3g:PUN_qJ1K/CN!KZWieopS]Xc6ZgC!61=,>F`.KJ3o'GXl4sG(D3ndN,]l+t\os3uorSrtV82ZX.o3\*^(4Mk*2MESg4Y[D1:HS$2Ne)(YZQt'[re0A0-0iU_c0M4JYQr=Bed[F&e'jcKCrF9oZmqZ\in%!g3nWn2=LD2V!WWG_G1>7cjDT_$u#VYJnR!!+`/4D\j=$%EQ1&E1n@(6*[dq8Sb2eD&a;>ucmrj=-E2-8?KPb-jD5e:a5f>6Ta"NlkerPfp*]jhX`<jf_Ei'@q]-%!rUhq[(S(E<2p'D?EVWVsn:$&BRUtC/EB]bJ*NP#:'NO@pT9p.:drckMnXX(B:Sf_$1n?[@=8PC%eS_RK>Y<b3!=(p`lmlSdRZ=AFHpGBUdZKKd6r>M7b<m.e\^YgJqWG84#Q-*5$'TM&*\o?h]hFK<PEW@djlb)-V/,$q(<Z>4\1E0%4$dDYdQ7sbF@$9Vo]g_"m32e)pod?=mJIRT$XFBS/LK!+.rq.AZNHOYm:Z"04&u/P0$D+](Tm(Hd3KKo3b-ERL.6UX$[fu?SG]qql`cGd*Zg3a$T,(3hVRI%_]RSX_FcnNRt9tUg9`0Qo\$Xn[@&VUC(WjA8U%WLF-3pk4\ogbBWYZ)03i0TZ"!5eOf-HA%K9heD_I%(bhJ0Z#68c$YjYop0<H/ffaF`QfM=3:,THILh7'OMl^f1.HmT$Frr?QL[c]a(b^;&dr1cJ(+FW$D2"(^jC#_"N,S=6bgKCYLZD<HH.)>YKSsTUn*0\m@,q-k9Q16O,6J`:R!3iL'!(t@=!mAMh)*CW-W/2e,>A,%M=UGHSbDZn_+HS?R4_rHQ4V(<=-*rp:hp-R/7*lt@],Z%QN;bY<kZVi+[rndiD7<?R77jB5a*OZa$kn3-*<d`N.fnZZIsGJlRo6W&\sbSl=_feONamb8)=0T+qUW*[iQVnN^,#1gH7P7PY!]jNH#W^:-RA827g?XR%gqNdg1BE9*J,4laVn=AG%V<0eFH?q%\5)'LVqFGBsV#>CS_0&g0Z`e%+5nlqNg2h*\+jt",jG41uB-pO2\GMQ:I*R$(<Ahg1#Zf+e1<<8"f&"hQZFNYI/k7^)7_G;]1(n6kN[fQeD`Qg%?H8]iSA+2hsL]H7q--2'ocP%#Z>R@HcH:cf8(Z]JH<h=kQs&@\7;=O_)"^2IoqCH4dNFerOKpo<02!&GTI!d^3j43?tcX[2e%i\LZg4.,*)k\f1l;\>fB\UMALiMQbseTsE)+Rnk;4/bds#bL%Udf,s1hH:Fm0fP=LuA#WY.c*R(5p%8H.&%JVX%tlbm%5b8b==c4"0_.$+Yo]<B805X7[.eAA4/km5SJT1ISFb&:WHdX3g*MHPh]!5\j8mO25D=&[A`PlgMu5BmpjZUQ@"M`K-*tPa1,q@d=$2Lm!%Zp,5(+)>]%1_@H*-gJ>,*>umpWR^;1NV3pCp)k>G*r+]b*+4(O1u2bJjc^R)K_7$ihfs[<UQK[fi4Io1[M[+]!%Go1m'MTR6'0H\Sr8N!qS]"+](lN8U>uY.%U(-\hOdHnTUo0kIl1#"=[$YTCDIcf7gN]Fj,I?HUR9pIn)cZ34COP!!.R`d[.ikW7,;(6W'H&GU$=rlXaP^T1U.2S4I:b8S99IS4e8E.c[03VMpmW*8*Cj5:#l1dDF<KWa:+1pQ'^\KKL@U%g"QhAa(ilUfS)cSUL?Z['t_=!6N3`-)ku^)ZoBoj@)5d@p1+D^0=KA\E8"Ds9bQl3@\>3e!jnb3)_!/X"na4J-aA.Q6A]jKI\4>FOluGO_`O8S1?9D/Ce.Z?*D\[K6<PrU`6g\CG\<4'^7g_c!k%in:PZ2]*d5"EG$_Wd52/F?^30LIn^@*aTmSbjIuu=Hee\3S*,/g:Kbf)LOWNTL!!7itrke]b@MfTCAiX'E8%t?i6@^rr@t[^'J5W[uL`\CiQCA>iu(q$CNa<?mMJ(.KClkM?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?*\0~>
endstream
endobj
13 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 33117
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 450
/Width 760
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ;_?0K7!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JXqC&(g$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7M\sJ/4#.d[#Cj.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.4Lt?^>6\NVKng>d7"`L;+20!;,PLnE(4B'eIZk83!-X;Di&oQ]:GXR?F9;=[c"kTID76EDaXh579$M@XL1S]q\uK:,0:e!ClFC^DMpBI!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!3AC#hp&"m;cLH=O@M,cmc_pB&1_e3Iu'EQkJ/"s5QXZMR*X3\*uaf;EF/qL+mNA`P2f9eUlJZH@qe>`!0NN`a5UmdCZYQrg$,sC5e']P2Ga*qb?n(Geo>`C<IcKlMT>jV.%gX!.%gX!.%gX!.%gX!.%gX!.%gdQ5WJ(eq;5'>p:[3uAA>Th^"-sPQE\H'-j<-$?UPh.?fN+QbMo%TO>b0hPE5>&?!'isBlit]5,edGda`\)7+O9eNfOgWr'a_j6nk?m.=pTq*5"p.M;\$8[E"bZE06IckS\=;QPK*ESYg-\c6T^"\@GQ`GF'1T5:ZM&j2R+%*sk4iC]ojTX'k\[O6^'F_LIE6*72>W/siTIfV_;b.7dU[K4#Sm7phMRobH"PS<R#UoG^h%o5>07rrBuD"k4G@<V#,X9X]#?"c0uYUSWB_Vd-XtRr*2h[AA^bJ_6*Rq8+WiDi)4JDD#ctrlQT?+TN.RJTqFLi:O4L+cTo^31''-Kc`T`iZ+LZ.4nYY.&)U;!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fAD!!fADn5R)"Wpp[<EVK`>CM6\&f(POPimB5`e(\WX96&/4`XlKV?GE`Tm@iqgg8N/0&RXmj"Fj[,dgV26F5P0#5n1,ULmR-oQkc44bJC_G)_e>lX_bG1sKBbE<d_.iADX7F^.&[-?MC8J!MC8J!MC8J!MC8J!MC8J!MC8K3`I,Ypp=eXn)("#Jgba#NYk8"Jdu@]trm:10p5:@*rQ00ala56M?(AS4OmN&V^PbtYL6X;fDqf%?1!Y5UMjiMi>S"]l[Bf9:[emSCOr1Mbq+eog\k.9RiTLO824Gol!4KbAE0?F37c%i7.g@(6G\Z2pa0&Q"+8"%i[[nYiA72I<fp4dSbPj@]ZKqaah*0FgK?:`V-Asn<j!-G(C>TB2-*'eI9;Fn7!<gDF1X:K'MX4f^L1Lf.Z+0I-#,S>Yk7*u;G%,]?_O<]CXT$J?fd$hpAg8RaHLc@K>BE_?gMZ@D72/W"U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5C?!U5DXk!n&-TSZD(fG(jf,NCJCE,E\(A\d\32qH&T"O5g]L!/dq6Mr;d(dH2c/[(EDMP'A)]`rjuc=&,9_oE2VuTArf-m0W0ef1C+!Qq&,Gfk'WB%XM3.pufQkjgLLcY%pK(bMl&^7N4*=Nbd;H*W.P)dPXn]0+qS;k+s87A*(pNHg]/c`DHN-=kCP0>,_6kb@ghL2;Lm>ZVHK;H`]]dofB:/!&)4F-f94L!6<?.p#a!jk%VOI>(TKoSjXIgi;Wd\oV#M&<auIbU8.jJ.%gX!.%gX!.%gX!.%gZ!;gV=NBE?U\AsRrYf7<kJ=&>9c/X=AHZA)r:+Dj")a/sa,q`l7uX]0B@VEa-Vl)*4>)BTCe)dE*P_XcL;C:DP6b"tSII&--Lj$*.e>COn%$:[5.W85Pnb2Gd4h[VL8e,0fUU+23Z,a@[5jJ(71MWh$tX*59Mq#uoBEI7oYS7IqKp$t?1THDUOrr<B>_P0cH4o5+'+5pP.7:`Y<=5!c!m(Nq+RsJ\OnKt"NA#)di!.K(Sp/[C3!4#jTWW4,b#.aUqLcREfN37O])4Y'L$"D<[VZS:Ol!7bge4rq\h]!>g.&[\S72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`&5DZsHV0H'9rm93`6l+n$"144np&J.(l!@B[ma0a6$7S!i%GEQ75p+[cThjCm<;V;k=#A[lB7Z4"hqE)`7Ws]6aSdT#prhSaJ4asgF8Q(G2h*=JDhPk81k-EX>*[sH'Ym'iMBa)-+*T+'aKIn;p]KI\B&>>U\6nYd\0%RuUCftT.ZOj?#r^>VqS1).%E!)$8kZ4SPE:?tr_e)m&2hN.!5_n/GK*Bfdk'Uc[XXK_:^B>4IF",Q)YK"1K`2A.gb`1S%Rr-abN&2s^=q-G8;(%6,Y0sG$isHZ_E/p4(SH-feFe1/]^`_04R>UXZ/(^TF3&1$VE,Xh>oU[b2i"(]Bf^CMU:)utO94&O)*L]/A"$Sh<Krc!5V(&B3EsN_Jd]0N`a+q`m5=/HY;c7)d!rnAE[?iJ[Q_K%2]]9)4&&f_IKKX8)8i'?1*>UaSR+td5MnT["`%.9[O[b(\$d+NCY#GUZFC40i;?=>?U=1rL_iRoqa$k9geoh+GBE"eY4B;$ps;^,'<_HZS+gY'qGkn>Vp0[H&$+]T-A<b*K-R=+,IfTWAb^]jK>ZD`40u0"O!TiIg+-(+l2aJF>!kOiL8AG4B$ai!DFS[`QoG"MC='/LFjCe;<hC1HmVQmu!o5\KK>uAj7=@rF(Ps"%+<'+E#uX@/TmMirT[u![Ihg#_0+Uj,KPC-%,okrdEW.h[+Y&[PNpI6+j(FB*Ho[ui@AVbHDQY8>,H'F!`csN']_B<)etk$TVpljZ<SUc=#Ki4rS`^E#'SGU"Ph5SVGK9R%\=+b9G/i1.9SES/"_XR<LFeQ_Z<Q2$^k?]XE&3(ViEo*/_G:I5C:.^=qN@\!F5FVOHs062,h'D#F0bbAfbDFXWo3G'7f`8H3f<UOj[irb,@JU.'kKB.=3:FSK%n54:8jWhC=.M(eAQ@J;VVfX"ap^HhYuO+_,_0)&oOi$_'\3f;2Xu6o%+(WLS2D16YFm"Yg\"q[+EHM)_YCli`u2p4(8fA#!;hbP@%,N3h;k5Bf+EX:rT[II-q5*?S&U[HpmbAE3W409]f>s)mC"Yr@<JY?(61W1[7+-&$ktW:4Rj'G-NJ<6is`q3)E$N7_KC#O2@]o06_@BXa`@=Z'o[_'TpCMbsOOm5jIVP#im'!-`A+4>3^14`=%YraMLugP]+PPEVum'_-\JdQ<d_S[GA!XC(uS_E?&IN%-6$kUSW:)V]q@)4+94(*J[K\($1YoPdHYTZr'6l'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!+mE7XNr1rp.Ia1ZQBDO0fbmoaq,ea'>s0K5,iL%,\c]eJ$2BtD6'CEJRYj4/P?p%5f_J)FJdMGWJ:=ooi:C3/N'%8Pi`dioLuGbV!;T\GQt88_3?LWaf-+qgrr@oT+,A"JeDo'jEW]&NoBse.Kila@bM'g<XmVhF`NebD=-_M7YMpk/)"0R-1u!M:/cj;_:Hgu4SES'"JFAd"!mcGqWun<?kh"[HF4=n1^upUGBm'FUM6`i.iH@rq!-J19EkbJ/_g_f:<nC0-6c9&S-fE&.EWP@u"VSZBYBk!Q$_EjJ59&kd%FJNZ\Gc:/#a!'DE@:Q`cTXDb[Jp45[\*7R["X/X0o=IJ8BAgq]e;tP'aRigHW=oL='Q<Z`%-.c>:-LtfAYVAZsSTWUt.S$Z<UVf1C::0A.H89:q8%"-qaL>+=Vcc5Op3urr?C]IjD4/Y7LT&m\XhFlIa%&Q$F?@fXJpV?K#$d<a[)SOT$lS\)Oijj!SZ!EV-H;cW^,tip:pb\TXbP%jZY-.U_X_5,Ze=o5lQJ9OiLX9ohuHX7]Cb5ak]A%Z:AhO7u(IWTq8J%n[:CG_]=X7*oiE);AmmRu,J)$!l3bo!E^Ilb=5(XUoMjjF@'fk.\Gr$AtUO(pBAl$6s;8't#&L4+a9V&q(VTIldF4[]NE6UA=kk5TZ3^?cDIOrrBo5Y/-ga_KOYUnS\@'QH/+&Y>4l-itsm=i<`nHkAHu5,,@jN@@%*O5F:uE#N.Op)Z&Uj?I\AOW]GQrV-KSD,a%j6>o61r_nU%7Y<b`e6a6>YnFZL%d5?jFc0`G[(ro#^rcP4#T7pHEN9+9ARS.G'%>R2&`.?Ee!keR6"U;33MQ'XOX!aqd8Lkkul<6@FKKNfmNgEsf,:^E8a<*0eK3)R@4'rn4lC*HuUL)]YahCn)aW-IgpZ0l>g)j!Hr\;mp#f<OM[+\%f4-@+H_2%,XpV=HL>;$>dXX(a%oO'0C)d.r"mtN#:%k_F+e$l0,f")\RHk*m#[^j'%r'`0B,])3ZaW(A/f0AacaY!K=hF*->_/@%CpTL=a0M[mX!6HoS+8<m\"8FN)>C98tX_(kF8HT,;iro@Hb>+ku6;@GHd2tbR72<fBCGT8.(-2oldi8Xf/59gsno'HC4gNNnMld$nmrrgh/;Jo^pT<r7AQl*mJ#!mhV]5,#gu&$*eo`4[W_C;oV83)<oN8;hIqQ;klM?rh]YMa?S'o$&'X9Ss>&4tkd7"e+"Vag!"VaoP=#&E595uC)30:`o?o(%]d9O_Fr,\WXa6b*EP"%@j#7cG`2:Bs<>[<d!e58XW%+.Ul=.&nWpm!djFXnthCL=G!Y5*&[(]]RW+*uA#):k-"("aS"RO]c'HIRBenE#D,&sZ+gKC(g_69d/>>+qi1AcY=7;?3GK-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-ig!!-il%l.;5@Wg*m(Okb(kQTEN'*!g\]D9NMVlEoF/"+)5PDO#@5ANr2t&>dqX72)S/3lL;%RKsR"-LD<Y\O</oK4?S,_NSL2Hrr>)ImuNXFVS!$)Fe!a/[f1/8M;QMKq2f4%ri3&)>#2F)%=H4dk=Luc`hQR6`,dJEXe4S\?VY(@D]AHf9_#QU/[%MeZ*sGiO7*12Pc;&+q1,*R3q],$Hn/cPAN6&I&k+8AO=8m7U<S)+U[&s`penS)D75EMc&52)%4hq*dibXM4B@O@/^K7llt5-Jd+0'Vm`?3EOtk)?N[gS9IDGRF&GX:3n@Tr>?W)X6[W]]^cIhbdc$7!^4C@)TM)M\Bpg6b,rkp9KfqaDHaW3k1fZ1C*d/FXCIOUh1%if>Nc;tFY8D-,r7WNH/N\Ok:W+d#2*:SCC)EjlsaGIDPC'IF'-FA\b-f+beGmE^-D]Ds[\<80kUPL-::Re!-]s#B2+ggaaLNBEMaak(9:ggW$J,u6e,.nHEhhX,f#K7`.]%$0nJR1-lk8THZf%ug=Y'aLEF;%ornT\s"D6cX'E^0q=)l@\1'rn+t.XOdV70c3'r,o(+3qfm,V5U6=g0DeHC9o'Pfu>q&a%a5tlOO<d<k:eUFSf9EPn63K/,VnNjSG>9T9":%V2p:OH)tiq..([<Ef9ZkV]#L7^.!?<J@n<biXZAu9a'uX1iPpj+uW%Od?&'OW^a'hi2j\o$!eQO+eplIJ22?a_DB'DBZhcd/K4"A`+_!3chgT"q:BQSB?WRJ[#ZnNM)"Yo)RrS"\)YKC&bM+jgWg7siFJ)b\<?Vsq#qk2HS:+q4+@_7HHSjf/7Z,I/mG;<8O&5N^C^rJ&5q?a!1OIqKu/,$ntn4R#fkn248;S1/IUV#nm#WL5%9-"^-Q*qRd`P"^'`@HrHnMVbn<*p-$N]N,#%$W:E9433+fkfpHX)e)<3a:\/u(U=7H3sUo]p7p=<;Y!m;:@A"3t!5jt05rr@q+(N(9odX3KlR*)2;h6S-tq6H[erYii1cM"I`O5b)73\H]3`m4'ZC1es!gS^E=\K'X\c#[24ph_q$DfMcOcI^@k-#>u/0+,D&+6-K'!!dlPFZ%.`^Z&I3A<oIh$Z\",5;@U_>5(8^(`b-;iZgd^Z_O=fn#rH#Y3sW,rYICt&GWT6Bj-]HR!@[_6ad\g_1sE:O^CJ5n\9t]!"JA"DVN+@!P&-YgnCKu\E"8e3p6/(N;bfcUK^Gc_[glF!5&/c'oiJREPXXMcVc6fkDLD%d(IdB!:iR'V3f09*,7Ep71Y!<@rcj*EVc14om9fEY2ct#\oRu@%.L4aku^Of.cX^$UQJ2?3#&`Q(!V!gk3CR8Q]Gbm9.M56eQeUZ3Ne[SFhKt591t`).@MW'5]m'h_=ag\8kH:iofd<hG<^nr.sdYSFuM/?:<ILFa,giR:H[7WRV&U3XB?k3T5u$k&"TkY,.$Vu04bZLJ$Nr9=].e<\VXQ,j-lh'^BliPhsB'>jKGHo8:kcL@6TIM;>SmV2\QTf\Y?1WiZs[J\g`HZ8IW,LIp.8>J;9tKXmp0onK+7\7_.%%k-LEg'V!:GY2dR3;.!=(+,N*-V0K/jD7)o.LnkS]i/A4eqH$-%]:i5!In3:>=Q@+$l`aak(>DP=k3C'a7RAePmK=W0c7@@ZPOQVC1p74#<u60mb_\(h0XG=\h;j(C,.bpSnr0S@;;$qF'N%;0!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C[]!!C]l:FVqKV*qK;B!?d*WjRq6&j7KJVi6R6t]Kr5taf&quk3-(2+`+G573I&)X&*[d5^I9Ee`$BpOa.K3iH>).?Dsc-nAq6Y;Emd3fFOGM"n0n=-J`D&^mDEM5PXPo9)</6EU[8#p-7p\/X&+^O[j6ek;DmKCL,du!GMup'p&i7<u>KOH4cT6ME&Yu)R'%<"\<r@5HX_0_qlD#FZiV.(h;VYQKP.[,l.PTa'/)\M'!<$Y7G=@(0calP=@GS&4\+Yr%!Zp5K&Oga(/mJ#d_2O)#:Wko&LdAoGm"Q2rL[@cu-&[qk8(Z[#hdL\#)11G#P(O>#ek@K'*a8X23AY47Q>H^Lpba:s@"9"HqOKr\a?iQ_iDM(/&FU(lfo^#N:a.?46Wo09bE,&AY(%=E$J0`I/4W<Y]7#K),O)Fkm\V`&^T'D=X!E64)@bEXkN`"CDRb<T$SD9CE/O&5O"!=lQt/+:R1W[I.!n_JVDPJFRlsC[jD;)VRn):3dY8h_6.pXW,$4g>jo*p2);-.0e@2fcV=tf<4%X:b+t<.od='4SQX`$S;3%2r!b<T(>ilaciHZ#T+XN?ACraSP#'E/nmI68k)YB6NBF=C"-)_jr4!0rr<MoGK0*r]!cc-Y`5pu8NlomXe-#L0(A=`gO5kQ9.rLlc+C,?IMLU7=7'`dUU\iNUB"[3Jt5=F!ZD5!_\m=22(-n2P)96Q:c\XQ;mAb*!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!PnV@])+.2Y'sti1d$7@]MDCP-h-hfVg)7brk^?AY&3-\G$,[D[KFUr#?+KIDN3Ph9MnH"Q'gU\b'Mn=HYI*tK/BRpA(kS%J`JnLak.,RX`_ahX!G0a\t*+MV5,ug`dIH&hdZP_?uU,JaJ4giUYB-BNg94mWoSWXp37SQOcRa;kY0Qm3WU5l`GGaAcQ^CDC0BAQ!eK.YRd9tR*5!YpaX+X&`7NH]`bjbk^R62d^t(0WI7IZ7=,\6:RV56o,e$ofPKOBT^3LsQ$IA3[^kjoHEA$pBVNqM;i\aGu4cVmu[nGEF\b4G\X.L;X9_%^0G^@fthSK3lG%?IP0*g=T39/l,Nt)"%qb=ZJj%I"Rlb'Z&?8J`KLT((DY@31B3$T$T2Q5gqRZeHI>0>2m"#imBrfNsD'2?qmD6T^T*'b,AWTn4_'8HMeKP(5a@DdA<+2h3nAb_&`iVUuOkF_D^P&8<!#D`<)kl1YPQ["M2b3U7CIkn`j(%^%m.3*Ti`,UjJ@jM##b5)fNWON=)'N>'072,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,cjiXIA#CI>b=P5n;bTHn.RP`5ULkFVmi<?A369r,qJDD_)Y<#3d@#QVpDnnZc$5pU9%UB1oUibM2X:Vcrc%DCc2Z+DM/6he$o<Z_)!ZrJ1mVpGs_l)qj!Z02C--c5_sli%aM[87/+9FE!KYp-OPH/`%H%<u(Ik%P/nnN+Ml;VPq!]<E>BB-QYk[*m21_ErHmrReG`6J'Q@!;n^&ENDmo]<f'aNT!?:o,%4Jr3K`rii90>GcfSiBDY5'P:t$@Y[1'[2@o('g)&>Qj5Qqhhe'@f7?Rhfdj0rCFZ<kBA%3&p\rR'jT%Cqf*k0X9f]BpZXjf$ef(K%CGmMo(-"[BL74)_aPQJ.<9QB%7j8T*QrrB""C;TM2in)$CSE,bE*:`\:;>?4o-1DA"n_]-=*#Mo[!(L&;,.n<WI#H5"r'>VE#7L"DB"dh:<_5p)"epl)0FB5&J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-tj#M8'=)nJolUBe%5Q[>VtR@R_r>njbg2p"Cer_L*H,poEBPZK^*AN2'%"$HDFcm5a*9F6d)oM`&1hifAn4[(@h[L7]0irS!bQ:,a/DgGSW"`Oo8L(oC$kHAmt_g1e!]42/rMQb0HF:\-Huonkl3d.b0-)4f_^%bg\^5e#0Y!V56l/:+QK3An?:.'>)0Wrf/l@h,?5gf`D\Gc-Lq.J+gs;o6$,iV1:6r;uD.#*C#mB+g^_-]s&M?L;'9nSc6XiZ/9k[_[[rZ\]BTO?afT/#s+Wf;C3r#G\7,!='b>2!X!_'R7K%(3jDM`'Pp>gd&XrTJ$QB2;d"BU>[I9ciUarM"6A9*pZR'$piDA7<LcZc2K]X[D0U0^q]Hg=O@!Q5N,?Z&d+O"Sa@[q*HL8gJL&@ET&U$g\-hg\Jem>f"2uWP]iB"6?Cff@?]BS58P;k\72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!72/Q!9m$l@=98cE#+\:SBEQ+_8cBM'8V,R4B_mpZPA)7U,`[N+E3F8i\VfeYRKj?BFDBaJ0DKJ_F29fE&Au6QdOju$f)UCfr2[d8)uNgQn=A!2lB>IXkrW8H6fol=O@FZ=lWlC5`i;qG^":IZI9g/RnbVbh^h2%Cb`[5'I55Tfm;?CG["diMh%[pU7NK;_(%^V.qoSM<*a!)Q86RYqEu=+CjOR:?H$TMX57['E`S_1@,+pWu;K;Na;E@j-MZC34llZB2/^\S<!!*h.:u0k+U5CB";+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!;+20!aeN"4Gar=c9!Ism^3'.(n4N-"nD8CnenON@BK"e#:uHtdkFhb=kj!"B.kirD"8ITYIg]E3C6M/'H"1\2;F`6S5:QY/52b%Opg_V>^W(LOB&,Q]0eC+[Kc%!lpn.&tr+^(d/8inejq,\OeEq4#cQ)+*Hf:U7jmY0r/9B+'(NRT%aJj[o0nGpC=)=m5N*N'gl.c'i27_P;Ls](E$8<q$;-Y4X;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!PdF6f72/Q!72/Q!7219E8cUP..<.cj!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!7L'@$Re5C4N.6qrcRcj`8,oF[J5<Q_Zm#_'Pf-)M),,r%+ca(!!tQrJ*&J6rr@Q'r+H3#Ika1%^R[F")3;b.+bfZfZ$[(pc!<5anW1[.1oa:M!8?E;R-,@.qToK"'N^q)4nu"RGiCMsat7`M)/'o%pUZshkS+"o72,`!72,`!72,`!72,`UQ$TYV;b.o8^h"nZ?5`W,lBh?ed_<\G4hg=<]Vu8$nuk7P;6Oa/IhMBe/i>`$@X1LTH!#^iT%!f6[1lJ'"Vag!"Vag!"Vag!"Vag!"Vm0Z%hiY@(U@8Y?L9?(A$nsZ&bHgR_su2Ce2@,/.nm@BF$-0]283'.mm%qp=h;nlVKdR6h<L>hgI'=(4\rJ"%R;oCfBjGcWP/"nG,Z_Nb8FQ`,usQon=U;'d!Tcjh\/Q.Bj-a"b!1M<Dp#WupugTfNi-sg'2+M*3H5aeVKE+E0QW][)moY[;+1I!FR*'.-1NmaiCtA!92_-&BKfGBbid=[q4#A'!#n$fiX+\(:QXi7=i.7Qk9Jd/#LtS:>"!?Ve0o__^nEFK,WJGq=T8B-+>rYZ`he00jeo_^<^#-XU)c`&e[#_@`'efN,(MlL";-`9/!AII-$WKXeE,/e*DKtRLuH^[ijmBd>-7M#i-?W`\ru&@\1"I&aTEP6_nIpVa\gUg!8_)]"Af?QIN@s=LZ5L!q]>EJ4Ig?*`\UiLi#f:<9l'$Zn+6TW72,`!72,`!72,`!72,`!72,`!72,dDlG"![-_fl]fO*p%(!K/XKhiG[iSPGb^+,.UdI.7U_Ea36N+\u7Vt"^)8k,l\rHaOkg&D$n)X%'@O80[opNe6^J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J-m^!J3Ga`WW)rE)d!%>Y/\-_p3k;0X_-0g3gQCVFCTR4),N6HK@;^@^D/uoUMBf/p"7lqrlng?kHBBe8H/[PTFXf4phA[b7M?Ki'rljLoP:[lb.Ii9VnuL(?sQQ$P"G;V)f#]?Tfmri`I1fmrrA'9ppDaXlLr[T.W(`2HOqq\"607u<k?ZNCMcPd6Ba[nJHrBdICnIo>!7)Ip0*\K'tB**j4>:&_Mg284Ulg^n4n2"iMDS+SW(]TJC"GQO2aBgkus&>2cm=:n2Wu?&jRYKFRP$W)V"[LF07lYZGPG+8L1@Gk4AbdYEM(qrr=;#[Jp56:]0K03aH6"e"H3URgbK0R*F__r(W,\q[*?"@n-7FiOsHRE+mg!hDCG$<0`[O5H\eMCZZ-.r%[_RL#["t:qkCN>9pb&$kC[;f"RcL!fAD!!fAD!&"ik%BcaiUr!L*si<T:G/JJ,pTD\oEU]/\)FH?23H,mc4q'oPqrH1@$$(qg,Hr9DE_u:.YMUu""BV_%TTid3S1QJl8U\nEeL:O<MVcdA!f/&tr*[78LX^ca%nAk7[JrZT5DRn5cbi!QHrU99[Qo'`s1qdMHqD(Fmbd%bpcj/E-cM4<WqB(>f#M*cr00G@6<%Lcp=%L)#:Iqn,N.SB(XpFb:o,#HLHi$a^!m)N==N@`Jrr<Ylcj.,FT,'O<i[n=S1JPHP>H*Vt9I(.ef4ce@_\5TlW^`a7b]!RV2=o_ll/BB8o)A^.'.4@m"9abJQ9WNu^,LF-]$rU:Hon6$A$WL(AghZ]5CE>8!;0'%j&^l?C"a/DpMq_!(@/JZI4HArp4i(4ZA"Imr[%R8,*D^?q>UH34pok'Bn"XeA3bh18RLnhj'A7cn/'$3:7Cp=bm!!j]:(_M)]mkC!VB`SHtAuGVBYk3TbQht>!1cql4%Q9>t&792:U]CTgJ04c2d0;$Y`eQU#GrN43K(E$^b/'a%jXg]C=strr<E3iO`>\[4\U6g)1\h/==9O44"4oHt`;/iU7THFr$N8b`^3Rm*6Y-\/<21B8#pcI4N8tFnO2uJf03O"#q%/j)9ZUc[m_l^!rmfGjZh*U*_/KX`D!JRl7OOgM-BC7'jBl/^l%s5.T'i/bhtFeLgF:$d#"&A$m&F+;=FM%iKW4_gWG[(d(.B]=A/](js-OobHQE"o'\/0+N6E:XuW2ZtLS1bRok]I49Y[5JNq@,lX#/htU",%tQSI;EZPJlEK&>OqKi`/0&`^]aDJ=pauLG,sP-#5Ou"]kQ%D(-m\F![?olGVQoX1X*1+]$V=kN:o)GCb9%Q`BfCp^@6>.CJ$\KD_[6L^+S+EHXRCpN!4q^WZ=$]efg7ur?oefamp(7#AX2=dP0?M$X*t1cO]_NCL>`.(/u32%]mC(dkVQ(i4qc60Q5F_%H'f(P\5;P4f:'6ui'.S6&[GYT<^\"*@L@T>>oaU[L#HqVl+R_6R`e?,(>`1f],e5bT#99r>PQJC!$t-:rr@=ooFYG<f>lbd^Z;?YrrDL@rdlO#]`"D(TX(uWXtF<W@?5,8F+=F;>,TEe#jM(X"=!:*Bu,$jD>d1Vn_lVq?L\H0G^Dn3[cN.c!PlMD5*aRkX5LG$iJeTF2jPD]UD]:c%TIc$#LHckpn?Z=(X=V6DON)]1*E*(A+]GscFsRh]suOpTtIgrURDu/N"86*mN2jP^Y=2Rdkrr4k1M&!WDT)ad[oG;=<;77;CIW<S_F,TXa/d.n\;oo9[=&O96fZ>Ia4?'RBIe/bOH56?.Z"%Co8_Zg,VJ2rrB-/e=,F1*T/M^`n,,ESJVqdqT5Pl<e*@(fCjpfSFV?!gAV9To,o:M2<[4GnRdX;MgmfZe0;C)miXT$qMquT?\lE"pl@bijM$LRD\=AOkoN1mmH\!mK<K#R)V*fr2#3^libX\e$p0&(-j/nKiAFu#rXdJ"3V<4'acbWfg?Kh,"8/eb#C)7N(&2+Y=,-n':Rt#FYi(Sf^.J*frr=>U=T8B(k(#Y$n@+B6?Pu3n\hrk*5XN3W.tVPKqXPXf_W(:JMSX3E9-FBs<>e#oY7pl(J)h9FJ(I[!7_NHS5Op(8ht@SQrr>Kq!-2H9]_i6=!'g)T!8iE7m[:%YCAM`_p2!phFUj(`&e04)?YfR$rrA/`7fNIlAc>X0o)A^/^\K;sYP\"W?aIH-[>'[Egtg8;_&Gki,IRRh2<MXhrrD,UC;95f%g_EGrr@o4:CcUM]W'OT2`OZpm!Ume&"p<`O5:JR\hM"1G@2C.,!Zt;2:?_JibsRa@5!b@h3>LjI#3U/5>PJYkJc<_FmfY#c)Nn1h-7r!\'#"*n+<aj9[mr:SP%c8ej>QeiREL?PQCNTF8Gn:NP%@3Si'eO#\:r&XR:SZ<W*"s)Rb3,IQur,.d-(cGZVfoL;"f#T>[e0/>3[0"Ait^iI;AA!:)9;!,,.7>KO<%0<PM.njWlU25d/GD=E"^E0)s$[Sf<lm43a[W8b<hIqHQ**d52DluTTYMXjO]GWtl<3rA0.Nj<$tN`?o+VkKao[\Js2NF\%!d=tYcj:PLc-h2ABi<q(%onf7gA:9>8$ZfWgq`jkYk>]jsFDJE\NG!kUA!=.jVgd$CngN/j!8#QhTFR_kprD=[=&QN3[(Vm1/gM%K$mYnmi)RN,r(un/KP*3pf4J6led)KB+(%Y8qb4]6e+Ge<]/,A$U^nObq17P=6IXkJM`a:5g;W1';;GIZ0:+C>c@&K'!;-d[j7e4FY#ZF+ma*](Gu,7S%=3/nh7`K_G;ccQcq$)?Tu\Fl'%M*9]c0nB:VDS)E<?qu5.1#!m-ipOm^11))L2^m\ITHO5^Q<4\C!_Z!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!V)Mq:\cEm^\r=5l@6-Ar-@Vcp!Q(cCWemkJ&t11rrDAiY1)<IN:]=A>AEE(?ELc/d)V:#!9SeqRBBWN5-k`Ui&t!#<WSd*&d!BcEEHD*`pX,b5[HP'\U8@Y.ESaqpl4f!qo>%:Rglfu#pqV4l?uIA!-!m@0g;JK_tZHo8Z-qqdo&Fu8>]'&HMO>ppOb*rA`>[d@ZA+F)[;m-E3&51Am*j.AS2IR.Mb"*,(\q]!.7`*ht\>dYPS*Fk?c@/39\]u4&a\c'rPaK.)^/+##0?oO+65;f"^P8rrAU:cg9ut!$Z:SrI'/]5T[s7Ab^nr)LmK`M01CB@2'=Dm`3[UT'8H\r%k>;WFYO(gFK__Q9[?l5T[$r2'$3rF<IUmJiej4!#/ER@oS4PdOqpXJArOMhVie?\Hoo(paSp44R1"C)=lHUn&g/CkOt%#I-i+?r7GM:o?W'IT8Hf!#>%_jJn[Cspt:%3ie)AkV/5*t/eE>klWk=B*>2TV!#qIsU%3$[,do\fGSC2Np#W9!el19rTq[u6NPY#g_68[m?_L-O^D(&>EWS@k85af<@pa6-cbHh_L+tQXLnIK[Gr+B&*=W!k?O+5D*<-!Hk'Mphm4haJ-a4I'o2`,E0"9gJX2`=SF#bK84BAA8]N$kHiU(DTNJJD7X2e`-oW:?2hA\X'n_KF)S"R6/3aOe]TF[q!+(u&@DZa+pPf0:L2Gr87))^ruX)THBX`nb6b`YZDa5!-\a8cDEik?W,^5"@s]O@dRntAmD0g\B1-QrCf!VA=d$Q*:@)7W*VD"BB)mVuR95[Zkq#D+Jhc[e8DdraD0D$O%N967jq%jA_Km@*_hF2n%dKr)t>5,E.?W@EfK-'+]5!V/I9m:3Hlk-G18#VKA44(RKeZhA:.8+?M_$QkNnPq"pP][q[Lg7.D3p%G3A#3KN]*e9gcI5C@/5aP(30ta%a4oE$-"Fg^8)?@qYUd*p@d_G,0^Q>W.n/)"`3_0-r/UOto)$tcuC!mKJFE@57q>8$qnS+RDdr-TnMCI)Cq@(^UgroF^d_:50V#L@MoTT,Q[G(DB7_;<3,>tt4Xtf%<a9ce%]MnNfqt_\g:[(+a&&E2[.Jdu1rrA=4IpX=G(B4AtT;MQ/q,c2?!*2UIXkrN`3lSaA0.iF0^J]_c]d'ItARUZi%01bYb#+%fT]"GPT)l?5DuLj!BWO>N8K'Klo8]KqKR?YdK`2VSNRV9;(3^1![sW-oStC^8n1Tf?r"#le]3jD[p_,th"-;uF&%-)S379uKpcDB]=XUr\*16PsP]Sb\;r_5;2#%HtIVtbt,UuAB!U,g=pVq.I.QY?AbPqR8MY^--pPhDr3RR7P-+<\5BfV.aS=BW0f?Kp*^Z;?YrrDL@rdlO#^&=F;j#7n$_,+YC'H_)`^D<Qci@S&7!^=j++/O5.m+KikqPAO/MSJ4OeUQo8rrA;aHnaH&rG1aALXWUP#5%/7G=SQo56,KZk54?-?Xs!gKNrmQdGSo*=mSA/,(MjA^6PS1\<Y?BjC1pF?WR(6Z%glh`N6>C%m)SXoel=OMDUa.58*6"I-=ShR>3rFGcu,^)t=#([a;eJ+4RHg\!eWj(6Pg<*nd1sFHmV4SJVF0#U%a:IOhjecc)?T]L)uGdtJjrYHPT5j37tLg,/Pel5&gH&!n1o/Ea5=^,+9B?W,DADdVtZ.nG.'RK31_p2uru4:ucN*3<4X'RF9lrG0<"-@a-)ej&K2YG48fBJSeD%rIbW.5fkJfgt<;:X^'Mho0qD[.ocaUOk9SiL\uS#HRjK^[_]^^[%nL,@7_:+8HO,n,!@9rrAeI]H?&:M_s62lMgiW^UQpXFB,)]%KRf_CXW22GkX_VHl8kd`Hr$fQ]O$9`uBat0Yo+X`dg6DYI4?MrrC,kUOUn$rr=PDU;#7SGQ.Xe#*&W_?H`8F"6KO_Mgt:q2.-+Ddf0;ZbBWreDW%HKAi0h?F'`SNDuN?uX8`'DO6kR"!$3'ArH++r)?BGk)of2Y,?[N5<8'PAl!Fu\hEP3@LW4i7-0megkpQ&*LR[`SXT3dGnC>;5gus^;r`tj9f)t':Npu8AdcoI#[!+=G`EmaQ-pHLqdHFXeg3a6ZGVUO=30b_t(%PQnR;cJ!:?TeBa-m##\UH2Z5h6d18L+<0[tL41]Mj%6/)/_>nJBo,p0Wp,0R!=pet*1T%bg\B:QnO3M$M_`]7RT=3Q^rtSc1MAT$P?(1b5K8a_tl8OsF@mh=3`L^U'%en<W?,4FNHD3paUp^\JR[J*Z:o<u_#sJ&pHFJ(LXuFkM5kJ+>#?rrCZsoUl^!n2q<<pub)#<SWX\(a/PlKmgT6:]T\`/)jokrrDUd1b\_(MuNcD(&$G`I$O6U1lpXMm_o9M;)-+j6!Y#fk"kn#RY]928H*aana$0HNSj\RL]7?>'ta?'rrC-`W.3D2r9+7I=t$+q$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!5$.N;nGC1nViGm]b:O4hH[-p[8;])iEo6Ae]P[ZK6KR\7nit..d@u.T1P=XVNTZBGcn88Qn-AQff>E*Ef!BWW8Zpl<AH9P$`cnueoG.#3'EO3PY7'T$'[mi<9=GMQ54a7;T2KH:MC8Sf^DVDZnU:E;N&=h?>mB_!-+J+g<>]+>?FB-L"2$jupj9m0G1s?_[Z`koj[fX_)!bM'70%VZ`bu4L4t5uA`MP)Iin@`uarO_sS9rl5)CL%t:TA1afuKlD`54b[jbTq8cWlq9<f-mVV:r>;Q"t.%\Y4jVT2GhsU5Ardn[4Y%UYr7\cI*ph`4"c)(TSWMq!.%YrZnnA`AWLM#L>\Ra8$)>P)N3Ba'Kb\8`J&->b_5uB1llT:X(c6m/VPqRehZQ*Xo=C:4epWVp?MJVO3BL^V[Qc-igDs`u5XU,4L&VVosY&(3F'a/-\D>Hq32@-c2##8ZPTpMW)].mDoMMk.K%":W>O/G\Z86d&t+3GBAQpkV*TE=oeB$BZr9F7"S9nS9n>chm;L#rk[R:SSD]R[u[p'*=u;u3Y%3niXKq[::3FZcQEH5L3YZMhM%cCU$-ZgC]FUIN$fXlF$LX$kJ%Zo(g;1PeL-)?[aa8@7k#E;oP4"J-j/K=BAnW(oL[^`dI&;WG`i6eVt-q$IgGh<qG@r1-DKn[1^lU9YINeh&"C38n0:c?]o)^*at9_lL).Sdhq7c4qDJU'[C;/%:aAo:<)jn<3XV%-!9Uq<iCLUmiG4u5ga%l7M9,Rs3`jGWhnuW3kZ;[+`fG6dWPFZ6bGu.NMYgS7!;T.D5D4DP^,sdsVUDXl["6C_P/^HLa1ZdHa,^UDINs7dkk],ISksk7=O,^]]rHqiq2aK1J@ngUHpP!Me9"oaHYC<7OhecRYGWeCJ-m^!J1s)ki=.H[>!pqW;>Q[A?bID)MYXm&hZJ7'U<`/(_DNiMWpoN1pKIF1M?*E`D[H2rhEmB=H@TGgD!1U$]4(4+`L<!E\'T%gHb;d4r9Na=-j,"p7H$C&_B';)/QGY#,ac]]>;ub0Y9<V<i#`[!*tYh1m6=%N\@.NdA;HucjV@F\'ER4n!!3!NXnZjMhqIpKep_==Sm]S'oj8:s/_>b8(a)09a_pC$3g*!*e"V@V0Q2[%2Cs@;S\=@fdJc#r2oCV=mn3A)UY0!>n6Ej2=X/BqCT4%Y4O`;6_OH#o8+u6t(>i,N?ni`SK@'VuNI:2qr&+"fM`W6)MfdoR&jh<%r@qYnd6Jca>511tqLkS&FA53YVp,;Sjt##s*rH>WqfFlkM?:a*B6)[XQ?1f#lmq:G-ipTmON+QFTi"8n%Y.W@r+,S.GN+Gm>LANqng<$uk[Xdh*qela:^=n$pc$."pKqQ]%o<o%(_AG#5d*QEVnl)>o1HdJ262!IB^K@h[YOflP&*4$l-:gE$rK83(Os<)n[JH)QbW:9rr<u6_nbtI)LmAr]1]Z&.H5nYdCQ<rF>Qf!bC:/=+8E$?n_U$dA"m7)D^4?h72RoG?NL'\XS?hZ=&!1#Ra%[N-mTYcN97g2M?(`f<OCAL'\+e;j"a=\Z`55B@Rj&d)86o3fWkGVMK8HppIG#1g([?g/)\Yn=M>eig.nIH746bV;afG3*/aR4`r?#Er'TH1;L'gpA\HRKb=<fc\:Nj/YHB:H%uW8O"8Ko<Qs&,,Qgpi@2jg]c%s+3(]N=T8?d]C;^6bbQC(=V\F#68Go*OIgV0uQ:!-f<q^BaOd_nIG3\CL5PMb'Gp.^Xg.SFitbj-PPoD\2\UcJM3uQL7_EF!P6@$s0FU5T_=t0B(68lo]!Wh;)a'EBt&hD^2QH-k%kHlT-Ge&"C9fp`%0*n&-`Gm5%8C]!c9];']OWOJ!NDp`&0&&9rP.^7/0OkHp6.!Eqd>9mbD)!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!)Z0!!TnkLr#_ta^Hf)W8VpuD$&c*T`u)d?Kr;a_)I6SRT2/QgSmC,Z=4_Oj#G$6#pfD%bG`C5@[lTb+%5'V+kUY%oU4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S!U4<S#UtV]<DVJg=[>DR<AQ/Go=>_TJPDCl/V*:$aXo+.Y>,$m&!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>@IX(o)3/t"VkI4(@u$LW)WE'BKeG)GnMnZTa(j82uon&'X/GF%t8h-3<f$Z:u(%YrOGO['Q,72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!=k`#MVtb=*P>]om0\XN3B*qBhE&\TR`UTS9o1G,lWl<eGW:F/lr$VZ^U73+'Z)ih'X8rR[SNm>m;*Y:!;*Y:!;*Y:"RBLE&GD<K6e?ql,2Q4Gp_NW++^ogQWN8=fLSKX%o@d_'3GqI-&K`H>H;c1JhY,<be,+Ut&'N%+!'N%+!'N%+!'N%+!'N[$K%u=O/nAWb^eMT1@Ids?f_s<>I!RoG!g+L(9G_X.CBm4RP^jh1O6g.$Td@^Pu.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.?_cW7.N@TU6[1R$37m3LQ&Ut#&+NpIedG-'L;TAIB2Kp(AqM/08ZQJNp5o3aZEp^Z,aED<.60=^4-pnZK>XAI?kX'^mX*]hQM;[phr*OFVg?e0kn)WH*035oFq>C8Tf)1AkD',5-.I0GF),aA"HfDrp(/'C2"^jnCEG4YhEeLg^[K60gCMo[1<H9F&Rn8FedYOT1HaS!R,p*^UquZ+'[!8E?t)[A_eSAj#-&.Ol=UqfQ^atrm0&TV7:Q^8^9+q2ck1r<pt$L1.;faZamjc!AtVS)UHH2$#+HC0YH"tV[(<`IW_&qqaGaIBgU(BhSR%a,T6[V.OtV=Shna+<=\sWq'BE(d?B;,Kl><=7;uH)`W#oGG]R#td]_c'DJdZ=/9r6l=rna[O5\t/f\YIfgp1/;J7a(nBGmHQ[YjWm=8%47]nOp&D["\L;hFPt&(\3P-h2,mIOr'780rUu[em=(`dWYm45)*cHc3WVd!R2Vm8im)E\\jZZ2?!PTq]2?kOsf&gesDq:;*'F]Ef7[iQmL4)Y"lH#+Z[f6$#,)NFZ:GI^B.?1fe5'Y1`Sg8"3JmAm8qg\>[NP&Ulie/XRrXk9Su7jNn.0;,LQCQWDL=8"GekFjHbaF2d!!d6&+[L9Dl'p5J@jS%<a8%\gK%MP'H6[@d<RC9NEl/biho]"D3YT.KAL/p;u1!j-iLrrA4!XT&:P"$dqG-f8:5IG*TZ!;REfchd<qrr>>"n="duqUaIH?*`tWJ?:\76()S_[>T<-PK3j(j$3q1Y9%@`%L=q-P*/AJOu6L1(!?;Uj#)mU]O;;,Vs3cJ;Ca\u,BLZmY9!DWj'<nLHEEIPP4CGK`)X:DhK)ek$iEM'iEmR/C:]TigIE3`'O7/j`tSRJD&('8=5nFZHss$5T;>1::9g2mGkR('gt029U\JTZ9rhU@DQH#ua-QQ/!8!sXQVdXR]IR[WD;`%;a)qDKr92ToBHIUgbd#qhF_SAGF+?ORVutVLWg[h'B<0]3jb:QI",s:SaJa7;C=C)329r7ObdQ*g\]Tl$B,rB&7Z-dPq!m:N@%r"<PE5A`\h=Zn7I^&*m%Lr(](r3gn\V%R62$r]ZAS2)IqYG`8TX"8@<ii<a-^g9j^+LNpkMQ5/tBE)?-:Cul].un#bVW!o3W&VDt'ob/<E?m?<frlP_`^XH^`[Y?c9,Ypbu$,b>sd;RTTL,#b-Q)MYQX>\4aM9lJa@^jHZ-SkY2&*PMe)3%ia_NWNEAWO@W5F[S@!KFn;NJDi,SUn;i85T;kO>c=JS\O!=kBgV^`KZ11#?*iGnl[Ch0H/@[M;X$m_!#L&e^YO='UE=,!S1e[Ob3(G)mPch'e3PsY/'C@#GVgd!bnianj!+*iFHipd.n&I4SE=?lcfpM/L"Af>oY-Y1`\7'l1N&i%8Klt*JpqPgl%pVS1r_)!RIV<U/i(('>?W$+F%F?u%)(fa5]4-dTQ&Gc-_68k]?)''.]NM4J8DB<]@Z#S(C&n,M_>YsjnW/IaeLZ^_nK_Z9N&lSqp%.A5hgI/IX4\780:"jd%ncMU&U[+<c\<]iFU^V>ldd?WQr"#h7<n4Gm1nTiUtZZWHSYU$GRuBD_uB]Tr$egSV6`lBSBc)JEIjaa!.$e-e?pf4,>Xd)p/)R;,BLE^.akW6L/JA@O@OWeT8B0S]K(&+CE=OW=h``K((>S.#M+DVlT_`mLMW?uVcqDoq7ppY[H^pil.!(u45u_=`%*1^gES\]K2gf\4cOkUTR:VGKpIFj=\UchROAe,![EYS"TWCeDZ9^">H%Q%^E<H./*-(Vr^+&Cp"_k)+^\?!CN1`=X7oqZd1QBYI1#d7:&b3TXe5Q9:]1Pq#MlgQn_nEd!*n.O<Jocnrr@ls+7OE,[!26JmS$90,3?C[oWDNHp4r.^`Q4'd/'E#^*b/T=dXXK0MP[.aelpq&(&"7\:N%AuZC8Bj"Vo5US)Os6Hmf?e=3;j3o#<n^^FJ1(rM'3M*4o_0De*5D!X/RN,o,T(&&u?jCNH9\45%cs!)>443qPu(8Y]E5E9P1hb&Rc\%lj@Mrr==]n,BphrG1M3+9"W.?hN5>R'3N=3r]3%0Y@>bY0m7L>5;AmrrA/2Qi2,(jsU?"b>7p)L],'eWbR:;r]K0>!-!E;K2gC&1i#%^e1RN*JOW9m`;j2<]Ur.$TKF`9.n=Lme_].A+93M/U9OTiHnfal98d#d:eir'$pR>ap"CoL7.CbRi[Za+V;=^^++:&LobFGk"VmH-lhY7LC`;nE\k@9<6H>;^($8SIZq#kD\1tm2GrfRW`W5sN"5#$)(Ie,*iJhbL\@dRXUMFu/,VD9.HOf_6rr<Gm_-cfjkPkCJ!;--_^Z&:ZWbMGmeQYn2;J!@^8JiF.PECK)@d0>7)RbuJW*9mB\VXmVOb:$"MVrkRnOLCkG-Q%aC@N0ZD-Wij\(h!*L4D8pg"T3Mm@i$IkDi+"V8/$L+>NO(mhO(A2oZaXM_*t<$o!D<[?S_9&&Pc_/Q0b^Z?s4\Lu<hF]:;\$at(U,5EGdYZ'D)nMWXME`a\uNq:$10Zp09t*%^f-QK(,')u3;8YLbMgY9.FA%beLrb9X7&Ou-FM$F,$=r@:\5ZM9;k+8\3c0P+LZ*h6<V*uMY'V"i8?Zb"Rk7Z&V&2YGhMBEQsN.IiG=`Z?[l7aq#*,Dh\Qbp.7Km9Z>j)Z2/V/t_)u)9&T?D!PuDZBC-0Ot5dh$N*TepPa54/9Ij<BotNp*^-84!SGdg'ED!!'ED!!'ED2tj1E@9n0YPa*d8p2JWG7EX`QGFq#8h449M_%(s=e;&bpGG-j/I0-((t&:2B1q!/#T6>(=GZ!ud0JK-QI=P@#FEJk)YcF7<75LK+%oBbE,k/P1fN4Zt1qd:f83!%[/<N.2DA[JbPk-I-g03n;@f;i`Yg;JYOq<`XiD]TmQK+EeUp_68NqUhR%#,]f8c(mFaA#>=!YLYC(7DOs!S<?[G%AFa]??#PP5!dK>ddcA0O\UsK`;U6>.%?BLqf<0K2Z\I5nc*WV3%l:OPoektbTp2SX</_B8cj.F60"%X&G?0Ut`b1$NRlh['f[nfj$LoZR/F]d5Wuhcp@R^:^%\gZtnSPXVShAQqiYY5SUfAJjNI;'/4&#3i3q>1<<A$g>l,<XIkJeV>.U(I&F<C>bXT&8*l$E@0M<03rkj2>#Q4cr56@_/&oW8X_5Oqd]YPRHIoFYDjq_l8.)V"XSQo6@2DJ0-5nSc5aF2Ic!R]*cKmMJE*=S%e!^In*54/o<"+hE6X-&KMi"+gf^\9q86-\V/'E!i(+1(X8Z^)E4:.tQ.rJ3MW4[GuVl.t)")J$O?Zo`DignKteliZ34.:qW'ajH/:5pI9B/^9@<A!oA;Se#h^.ZG9<8%i+\3O$!`Kpchrl98dF@9]_tX<@&!9a$#C^G9."a)]sq71Ms4!C;M-72^ECGG)q-!kd6t5(VUmZG*f5^l;:g@gWgj.EOC>[Vlb4,L:hro57-:j]g>,>3A<\AL[[GWg\_6FhVVMLLJ6=ef%/t](-0b>N-u55!-R09rrD,JC7droFn,Aolf8!FG^hdNrrD'k#N:E96-(OjcFuQ!rHs+`&*H2"G3GRh!jM\)YB9dEcp`2'm4%f%0;P5a=1IIdncH&q!3^ME!74/ZGO6jRoIm#4bYSNFn72Gi?D%5t!rc3lGK!AR-JHfEE&I6J_2nC@H@Pi#q,bu$'gLcKCHqL-cj.Q^pXe_<A*_tm\a`b<R.P_c,E@,/84'\Og+fu+O/75CT7)0rpLf9]!9@D65O6lbr<,q%a1aM%(8Ke\a=Xe+mH/\XHC.:>+,Hp<'(ETlN&CC;HRWE]Gnl]'V![4,?DmZjrrC,i9`G*q#Plt+n1Xc5NL0T`PPJ#[WVe@C9<@n5`:@YepND_<cno0>,b1L*VYk)r<jgs>HUYElT\QLdSn+pAM9+stfrN:[,^a+.n9)ogH@,e_;ZIWU_F:)(;scgiSVQRe50aW:[JT"67%=e5]_g\Y_^hnk9a$(/>hRGbO,OWu%:5[e-]b['R4P3`:[hRS\<#fXmtraqBmj\9a,&$6f#>?jE25+7K`H<]!.7^bBB!Ep9.Mm-dZTD^$H(<*PN)?7P213Y\<$Ro=3^aF#Y?*OFF8Sa6i="L%u]?996JSWi]m&Y5T^sp.`$m:F'c&Cr%%;5`&h>nbNmZ03<gZ`A<m=p#@Uq=&-c)=Tj_;Mpj*X`nEun_C)%Ke!"Yn+HtVI=!!hdq%+YoZW2c..E_)gFa/H04i"!LbO,TQ$1,68NN9)k2@E:=@qanf"C=-SG2u.>Im@*YH!/&4NM4.NCkP7pZZM[bu<NLH2?a[Ytmd20X-p4d^-R@k<Km_'fD"`(:><)lHEeKI@#/9o:KJi5o&)[Bef6@4+J3+hWr$0e*CSRFm_X>i#K9Y+>3QV%(qGZA9L2OXMi>[1lnlV]V1.c/c\"BdC5I:@ir.ls)!+"<l@Xne6U4>F4rLlI:H\_U6QEu#Hl^D^Bj!elR9=XA^2W[<:^s-SBd%Bkl_uB^Cb?f%Zpj6!1-0_baX]jk+]8A$X-j/bZA)eY`oZJ[1Mc39J5kuX[P"g>%iZ2K&J&E/WXJ9Re8n>u>HWNuZ_>aKT9-?Np8@e06TRT#p*s_ekG9Z<&^Cskj,#c,?Yah$Q-i>@p=8$k-o_*Som^5(i>G_]B7o^T0!'7sd(W&BJGfSebX*0%GCg(^(Qal`0lf^k^[*l>SMA/T5D:=">!iQjm?8VVR,e(LVbJSM%aVcRGB'41-*g?[RrL9qgc\&@7SW:Ek)6XeF?\Y`]+lY#3-LHFY#mFU\0Kf]E\,I.E`1;/Q!281RZF:q>cuJl4>]5H/]%Wj-&H/ZsXJ"_=41=kKg42ALp^cABNH`5Pfj74t:LPoB)3.9T1-__@48=a'LK_*qepL0cQ=eLbdqf2si1Hi^Ia(:Vg@3E*MuNchY>P(orr=>)=8r9'?e0`k1BSm5>4oQ^i"(Y4m&_r$^XL,B,0HUIZ2s.:]Tk\WrC).ZiEuBp[#b(UO8f2G'EQ8PBL<lYCY6s50a%2)YEGWBTp[3%)&P((MYcAnGPmW[8,`5_!;%FA-<MJ6W7n!TX%Io'Cl/5c4VQcBMEG`erO79)*!Y>=O3])X%c9QYHfC(phtTuNQV5h-#ucr/d>+[([kuag/Mbm6!%Pp[!VERc5A7u8nSNmY!GcRKY;?9$p3#m.l)iiV;Fo%8OI>-,GZFqLO3YF/ikLIKK01R1gQD3qVXgDRj-KTn_`e*a4se2J!++*'9'F$($^hr:dVZ:;[=stXfd;53C.W?Obu8_F--b8`pGjeE]iRr,SpWhLVkqAOorYU(]7`nA8(P5sK/ShJHqVr>A.5E=+:$D<YHTDWiVrlmpd\<QDQ[e5.)N\W,`28#H@oP3n/pWnb?p;<C,<5ZaJH"Ac:X5@>1EMH/RganQ$'HZX"d?*`)hoq4.5%%LS;@tLAOl-q]6:>TF[gs3r]3%0Y@>bY0m7L>5;AmrrA/2Qi2,(jt#_hNh>l8mf*:Q["$Z@<mgpIj>CNK!+"(LM?*OADBlO:7Du=:32,3Ip&J17rr<XYFa`:'&5=ZKlXLSBJe3B-T_6@)YGT#V>eR>Xm8cdK)sh-\pDC)mVusa&5JiD$`n&0#h4qEa#ABQ2r5[Gi^DZqff6eg@*CS'cje@1sM`FS3YGF>`B+:2Y1h^8^WV0;-%oP/u6c<$qh=tndJlN5=D'hRK!-HQm`r6D:L8!Q8Fpm%r?cq.,Z"N0@n&9^EVs9TENf=7@'9BKC&<mj\@l<b7UMR(<5fUO3nBLm8Ia=24(N%9,.YHLd70%RV`/bhmGg"&"',b$@:q95DZbTC`j4)Sm#5DQ-Gi^3BeAlK@LB_I6Jpdm+E;aS>%u'^RfmGj.Q5'`Jh.1>G,\57,c@.SE=5j_kgC*%&cY22\9*$8UYncGEp=I4g,.R+pY*,Ghq`>c>>54KX1]d=5JA:0;pj`:U+o_Ph7=;$';uTC$]Dhk<:]0PDcN/O;5Oe[QrHL^0!2,5F:ZA;MPg+FO^7Y5J#HiO$+7]Tc5O59I<QG#`nL`kkMq^]6ZJ&J1q#THApGLTPc6)T\eN`Aur`,<Te)C"sEN:/oBt!JM$_S0/@k=F"a/&cT57Kds+!4ip7b>h!'tT"PAXbl8]b=9AS(Lr2e$Yi[",3!o&)o+X1p(ChnGW-ndr+<T\6]J/O2-YGY7#g+HEE^b_;Yi5]=6'(BSP+[pulAneMU,*l8k9KGe>Yl_]A$\LfqjSOn>iG]Pl_66bp2#>&"_e1X)?<_FX`V2>04nXBB?8<#V'p0UCF(goN`&YF^5Wht\/^htm(3c@A%'_EJ^InW(,J9oQ>G1T=d1PE%hln,E@prY+T=#OrN)NhLZ2/5e`C$OJ*A+SQW4rr<*bjJ?)\!7r%d<V;UW'N%:!'N%:!'N%:!'cbUI`"GE[b"/@2*oMuVPY_V(^Cbi>F5\2UgtG=;(@j2C#KI7KdeF'fg4t6%;fQ[OgKAJCJ=[U-NI>*m%gD3H1XaO>Tb-&cm\U*K6g\5@pljWSM=c(aXCGK3DrGBT)]n!h4e#+>jl">ZAWhDNCuiX]*3k][obA7Gn_:n6F9SdYReg9:W=iTf,hL;Hpa=#-3ChIM1-Hj/Zo%d_L)r"tU^7Nj3p6:6)aL&,W4W`%BCXT-,h+,k?s1[m&00YT=32L7dHAl(:Oce6'kl`GH]7H0lS!u6(r#L+K:p\9!f#VfAdED]CGXsW_TP^o_ChsYD=om.(//]-d*N"2n3>nbQ"-PsJZE'&[#qn4?:0ESHY0rQ`1IXS45p,ZCW!,UbpZNP72(DgDVZi**F%K8MtC`:,grNS<:KDT^ssBB!dM$M5ob2.iG\G>O68bFRYBee3gItNR4g\)+o7CkqS1slLZQn\")cS]8ZpC0<:p7`Xq0L[^mg-u@FVqaYTaY#C8X'Vm8qXH`fW`q`h?7!!$-anI!>+9r^rKarr?=0rdlZKrr?ZWq"N@ShG<HBn&4+=?7ONT+R6H0)GIJ@boeGX,6rd*hnZu6CL.m2<F&qMm>T8Y2g<8T"4MWnrr=7OX8`0+Z@D'b^)3@<F8l6QC[SlbhHR/oC,YR\Bk4\p730JT(%Oc-$2ePd\JcI?,khuRoP_VTR-aeeBt#l2,DlQh8"cuB%heYE`KhfY]X,2+`Yp9scd7;I?4kQQm627RUg1]E^&'V*@q3lSq6L##iSTVOCR79=G=)d0BMLkkVut[9-@@Z>9KjN2eSQ362XW!:U;Yt@NTmq0g:hKYZJ7oGOMQKG3p/BL-\Qk[W\B::h*On'+?9=8dlniN$bmUE)P;if71:^fD1Tf<3bEn*&&reE(]OI=Am#3RKpk)Ln13RQD2ta^6*Iu)/E+1FP0QH")%aeh*+4_,b2,&O2m;G6SC6YfNHnpu=u.6OUX4kupMU345k+cRiCbUA;R_6kTi@I@>U`\U#/!%XLQ*j4;rSa3D),HVf#\9pK;1.`ijk$riRa!q99BClPB.d?$V30(qU]NB^Ogd7Q_N_@kr+NNHJ@0A<9Oi0+%cOrILL_J9@Nn@i*XX@NqfUR!$p<%rrB2+]P$2A_p9$1Sia6le24.4[Z<M@Lqp35pk>VOC>K-E/8V%9ge/5Y6.D>'pn9nJrG1iI&,uXN\Yal.XFL'PYEB^\5E19trJ*==;.!VmYfUaUfKh"SOumbd?U>H=J34)1OGS^sUs%'7KTF]o5D7bHSq6D=`qK6p*PNFMF4#1?B"j6!Vr/f[Nt8=8m&>JNgYlc.I78P(J+33O>&DGM2N;`Z*+]e&1]d:b[tuqgqiA&9C+rmt(sIOUIE)H'HsPaDRBHHjWm>WUQ*-a&HM+IMp_i$"InT<2g6SRD1_utAUCAjo-eb6gXmgg>D0G)Hcu&d0DfXUnKmrSOI!\ZpC%+<9%`@3TIk")^mt3@*/lY#THKV^eN;3;1%6IKHRO4Xf:17W&]Or])VJFFm4:gHIY("]6V-_1.E-Nis3peeCJm.Q&L$baph6/\MUs,cmLtC(*3Nn*Cnl'X[qWNEoI3J--r^h"<rr?:ore)fA4rX>ZnQ(Y0h(nj,!(iIqBUkE07L'[rIhK-3c"H#/Y@1iGRc\:68B4VK-j/JmJ(Ma?nG[S)DMeAn+?L\Ai1J0+7Z64iNE0"+6^n+-l7;2F.OTj?[#.<+kn:$-6](m5TA!*>G)Q@[rr>+Ohh0hW;`(-@cgn8Fq!6ljDoD3\7nBn3OUA=@Vl!1.?OXXhGcO=(k+-pMUrs4SCeMAPJ].V;3F<-gQ4n2rD+Z/#;WYa@qo6A8YF[p/r#sSXFij=$"qNmZK>)##mjiT,f/*N-n/''44eIH]1s=Y+D6>+J\.Z7+_"q->C&4*dX)7R")hae&Pn&QlO^AmEi/\S?r1q`D6g#P1MYa+,<f_[&GS8<F;1ui+$"cML)5%JjMC>,.QTo.Zq&\Mp!3]t0rLX#hjF*Ns]pcMsNBRR:(Pqup(#G4Qa`@H4.<Ql;-c'^'G`Tb60UD0-dq#n;^f3B-epor9U5C?$OSGMj4f?2GC0P^HSjkIrJ4KmY2mG(X6JUAr!3,Q+bg3/3YIaCD2B?:!]$med@CV99hi3#Sim39a-."LeKtW],>&GZI@2\+\:^>HQ/uR[?*tDN"B6@\nP!fR*at^s.YEh@%Ga@7+5!$<hZTG:N#bu>,!T'X!4r\ae>e#gE/?US_@to8c<Di(>g@9*tXa\/gNn["OV7X0,=*26=RJY>9;u8G%YLgPFMuNchY>t@g&Y%b1YcF:M8`I6eJNa[t4>AauFc.'D'+"NL`-g4nTBBOqIq9CjVqbEM]:tlPN'2ui%t^&)Jb1hn++q4MiRp=.VopEdD[D0S,EX#9b!=!>n1PW++7UD)WD%-phX\am1!(!K"42qBdl[`lbNl+dLI\ru0[B@F-j/]ENJnt<?D,G]$Ud;\!.bLQ5>D.XOKG/RG>J/C=4_p91gNIPphOrJl1XL-gNcn\HCPS9q;0$J:Q6RJ/Yme-@&kc^3?/#f!.B!"rr=)UrrD`:J!GE?qaUScaP!J@f=1FVUhp^=Z\96)PnXi!MX]M`*X_EBM0qa'EMVjI>f;_@Al:TKTFN4)+8hA5^['TLl!<K>)5,5oVeN`l86I'F%(PX7+P&cnhZ7tg_u;cYqc)#i\$ci/QXV\5N*!dZ\m;2>VU)0s`3S.AV--?^%u\(2i\1'q]No$IYU2?%&cpfa>5I\`n_](D)\fo>=LAFXOrclaI78AkN.(oqH=bm@)B+Og1.bFM%\qM0\0pcQMI;OaFF2A_!ZY#AGO`_oG!78&D04Sd;)PbT/CL^kA*I+1"oLS;[IFaL@"d:ek':1?63-r0kt0k6!/#_Of.IV+Ao-BQk*CHM5*bcDJc$+XGU#X].l@blF#;s*dPpqt#<hV+r^hh$rH=7uf?2f3r._;flahR#?X.t`dBE63!*n/j[d?6$8rO@.O>E@$k=kYNj#D0c8S$3q<(U)WjDY-m&#d-,V4DD<2nF&.l0Sg2f5DDo-/GZ2=*%S@KdDSu17lEchNl;^eg4aV&->''niquG##iIl12?Y1,T;:DaV/X!T3l(n(-WE09@9rU.;,Mm(U;]O=s/X&Xao>O+P$JlM*DW[9cq7hG4q9lgtu@+@uV[LfZ;',I-Z:OkJc.[b`_2a,cSfI`o)=r9-8q<0%D:JMatA#36[!TIWPV86PPkg.26N#8JhF4E_Ut;V>*pTIM3.jN)''tUjogBJ":U%%6b.ILTXQVf8Oe-Y;&@(=O41]Y@dL$%tNermH9WM'W[uD@!`Jm:4+/YO/-$*<ng0pD^2[&ZV_PP[KEJmK37"G4q(]]>)^&MLEf968SRS'A\D-WEP)\=R'&QDls%:QEP`g\5T]gmHfA(gCZ0W"-V_76k4\"T5#Yu9pE\A6p$.i-#^%(N%-fnJLqh?g(e[:(5;@)&o#t[L4_OrbcN/O;5Oe[QrHL^0!2,5F:ZA;MPg+FO^7Y5Qec#i2T^XRf'9"^!`"2h;/*F['Igu<YX*F5;^9Z05QJ-,/B\X2S)5%J[p2L$3O=mO4!*r+cY>T9Vpj?k$)D(XQ6[K-W7kr^.d%7Y^r!r51Z/Mf<:lAD]HY8L,<&\fSi;P;*54M)9NN[JO$OJ2gP_-(NkG80)pPD!5i/\Jh,kmV5ED"+qjq^p7Y")[k2oM/-VN^"$q[4@*F)(p&Oj$%G$Ih6ZnY70KfP4r=gP3[h4ra8Gigk,T1O3p4)cD-1,sO:NK`HG&m-c7<GUDN`/`a%WH!0Blq##2<GO6I[%hNGqo<k59oriZ1a+nL//YLj4<_J7B?<b#_jOZ-V=25'\q@]p2.c8ulTe4[*Vuu4dKNdK/JaifelMa'`%Lcr:d;h::qSpk">"531/M-Q#/gi*_A8f!ForjBo^)qU#::N"&UKnW?W[?Y>ec#_s94-+p967&s<\mt7[CM9#?3rV4Vuu65.&)5!.&)5!.&)5!.&)5!.&)5*CAJI`PQ3`O.%gX!.%gQjHAXt\F97bc!%=S!!%=S!!%=S!!%A0YW265=&1AP!V4rhI.)pS\70"G1F97bc-ig!!-ig!!-ig%c*hZEY5QCe+U5C?"2M'LYd7"$L;+1I!;+1I!;+1I!;+1I3dHEeE=t$$FMC>,!MC>,!MC>,!JcY-bU4<dT3XT%=TE:!!TE'LgdJsM;.;5@UMC>,!MC>,!MC>,!PA9q)b*Inb3`/<[!)Z0!!)Z0!!/(I($311$'XU[;72/Q'QtftGoUQ*(3ei?i5pT$>iDOb:JHQ(rr+fgA(=.S[T/ZXV+/V'rX3SF)r"mtt6/ns$DbIUKPqH/nM;)eu!$@7oi"*X7*=4Y(!+hiAqqcX/q9T@8nQY#N*[\-Q2MN2SPPa%#@)&oeQ07!-n@d/+4Afg$"D+@b)J7"sJFf5uoO$;3`&CUFC:@6pOS9+:g\`SXHlq9`+2N+BB@EQuX?UtlIHR75L>E'A[Yb2)8C/QA?nkR,70"$!70"[broj9ZBVL"a.&)5'J9lc>N-(eO!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!<:^~>
endstream
endobj
14 0 obj
<<
/Filter [ /ASCII85Decode /FlateDecode ]
/Length 616
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 82
/Width 82
/Subtype /Image
>>
stream
Gb"/a6&ri:$j6D,:NruG$kbof_'1UZ.U7hi&G^dUWiE)!HE'/2^[p;V]dPghMe=OtTh]6F)e;k.T4K5s[JFok*]60':g6%dWNW&iq9pkN^XW9VXX;-uh_"NWe?^$X_>j4G>a9/=l`JZ)4,d86j0P$IDQS-YMdj=\o=gekmCt8<ZhgUPJ!&(S8Zn8VrH3/"2m`5")3mQ]Wnc+[2c4p.FbSUN]qrBJl_RY]`03"JjCFT^j>rLY]D8XDSal:s/TI9Q6hG9]eTo3aqs\4Gc?VaaHQ"cf\_cnh4>VI9F\8e,Um!pqXBY@9WDc9LT@<UhIPPIcF\5@F]t[/sbN=5#@l+,uW7NQBRCA;:5l+IZV+u=3Y0WWHTs"!T;X`orUpBfu=Yo-u[5rkb9eu>73Cs>P]'j\fm0V9+6i("acdI,_5?$js?VQ]qC6CF3gRBKj$2NZ2WJSC$W*%-,cSK>`]qXqXr(j+`V78Xk:VKU#]AE,h]n:W*Y!gp!F5!5SVpm.QTAdH$dl0WV9?j:]4=TfgH'1(55Gc)OgA?uUUan[??KAcaDQ3Snp[lsL)a7&s;sKpAFe3fuGBZr]]5OMmnlpu"rE$[opJP'm<E3&l'`A%oJ/Q]~>
endstream
endobj
15 0 obj
<<
/Filter [ /ASCII85Decode /DCTDecode ]
/Length 19020
/ColorSpace /DeviceRGB
/Type /XObject
/BitsPerComponent 8
/Height 115
/Width 991
/Subtype /Image
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!ic5#6k>;#6tJ?#m^kH'FbHY$Odmc'+Yct)BU"@)B9_>,VCGe+tOrY*%3`p/2/e81c-:%3B]>W4>&EH1B6)/6NIK"#n.1M(_$ok1*IV\1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,:U?1,AmF!"fJ:Es(;%!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^JXqC&(g$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$7MX!$K/Q_nQSQRk.,K-gt:LU1`LWq8u59J4Cs;MGI?H0<-*N8nt`OkU$A^75LbS=S5X=`D(ip?&*N*([3Zm+'E8&iXj%gELP<.8OpLM[g1NBE\P8JURHaS":>/a=it#R5_pH8uqH"Wqc\7f7]4ih)(@g$l36F?NC,,?l*+RcF9fd2c=:Xs77RnZ,r)Ma':C1_;;S7`u@PY#h@0!`,-b1:`_0dKt7Isd?GZRmX2\qmA--fX[S2)0kG-*ugJ+=d2rI2fe!2-_@cI5WuG</Kq(9sZ=l7aHY=##OH?`44]'m@.f!!@_lNM?FQf:maEhe!4lR",1Y-adS5B4*_Q(OSQt]H)37CO66/d`dG2+:<:pER%,Lr2Z[Cn"A2&l[.r0h$ih1&Gm'.nHecRpmpG0'&LY(\$pp`Zt&i'N[*`6i1J$#c\":5h0=D37Cck[2!H]oh*NhYILVpt[[f7MFh6?=9W#G'B[5rZ<+N6n!)or=^*.:'LPe2o%t\mp2Q#CbS/_`LA:f<BUT^YuTcRiS3XoTZ#DVm(g'_>/W(<_9D:ECJqo&+$B!Gh?jT(YG/&Shn7K);71&Qoik?Z,_]G%%7@`]h%[#R`I4NiR\1V*AU*l>C^[t8/D/2=a414h"E9lpIJ_S.eRr*aG!g39'a&d4%@@'4ft,T`3=(AP2]_>7\Df<ERPE_7M`#R'4?H]dPoo^*/_dO)Mk:U5l2Y"38STn(('j.P^C&'#df'J.#bomcT<V$.`2/qA)Y'(M9Wiu9GM/-N5b0=FEK!&4%-'>^i+^4!FoYD2o!Mm(liI4J4(N6Ho6),\(C^4'KsqeL6^jfDNAngomFJ^N!:60Ug/.(cU3ami/`XZRu,%8-1/V23:!D1huD3V=WFZo#H_4]b7_e0.jpY$tO2?`4Ahc#DPYJ)it(qYZEM20BrKrrA0/7/m7j.)5Bd8]>]s#/p6Ig=s:7&u8@D2`nWZ..nq"lW!Z,TNTG-=Bf(r%QZF]&J*lHr@8!0*iXYKrr<tlGV`$WA-h*e_!o[/P2=>CHN"ZD?6&H`O5ZQBK$)Lt-m(S>TY%\45LQTu0hKQe*'Kq7*Bg$4US;&JJp:ta8bqF!H7"KPl(0*((ReXX:DRobE6*GEFU"bWdd/h>)@P:Z-]NifaFNee.BM4Kn=R`Z\,(30*?O_Jd#q2JT:$4m3eL-TcUd98pM/a$9CXZ#nBK-[9_."FYMP#i6P]H\5T`VTeSiZ\(qnF8gN+s:PJTh1&@2<99(MG&qF7$S_l7DfWg>c(ca+8CMCAS8@.tq<IB$]jB.7p(aS=ouS+jW;\l_22-O$dIg'?qLrr@he;eP)a!O[8FVFX[j.4>5&]m:>r%rVl5Z/Ub,qlHHJMU,))e)>Ofm@o1[EpSpk'X?qC8koh/X9Y9q!5e6PJ*7iNrrCp_rrC#9J&:d'5Nj&cJ);^T!6&$7IqI>_c]u!<qHr`q,.Fth5I;-O(aAOZ+5Q9&J(5%ZUck6OTGpaUD:#,E,8tHq$SYGB:B(=`.d_UTi[\pUBTd,>ED%Q*b,&PLG:+EPX2@Z:#9q=F5P<-J_RT&mrrDUc0)kq;XFL']6KOGp8.MO`emS"PM/B7s7jN'/.:lX:\8k)!qGrFr5pUsc,b!fn)1TaidJj44PCMdc\K?\-,/;Y#Rr8JoY!gkF7EGcP/^[/V1!-+Uo5R$6CL7l?2l,4l]Ic;Ea@JO-:fJP2M#dMmX;JZ360A1IV"f,u3.JZK#!\5H5?dE$.Gu3c_Y,CWD&pUS;<HZVTpVHgoH-]iUpl(Xfd&;`rr@2+&PhuLQFIeR(@b+SMfcDBe(/&h,V_'sTFem@fUl#FF]-+MZ-q37Z*fJFAs:J^NHTp+"$$,X<b.=9M<'eNU&rQZTEDl>m<nupr)rP78aqb:'nt]b1X,CbLWBfhJk-d$*gP=1gr4PS(!I,u.8W&aW$<M!)V7TNi[sn_p!ef%=Gke*laRL*%t1L>p_A"f#W:bp]HAc&@W"$snqfM%*`r3!_R5pkUNO0'%mcqI.hE'ZY82Lge$LRbZI>NEIH57QcKn#U^HKolo<+.p>(kU:K!e7M$!C:LWl(k)+`mM3bVmP*h8:59ji6ipGQ-eRPPA0Y-KCg^E4C/B:/]adM'p<X&N#o9f"i1"],:OZWr7^n)tfI#TqpGb*e&/4Q#(c*jB&#=T+CiE"b^Y$QYgc%T_[#bn@u\e_Ql'!!/*BCUB@rlVbXhDb#"C_T63BHQRttoHV?5=EO"0\qSZR8LZ6kOOk(tT18;n,k]f)`=-0o3%9P>,ff"4"ml1$nW9AP<qDX"6e#l:\XmK72Tu\SdV0oa"qSrB#.S<8_"r<1Y\QrJ50DJj7[X$;;rrDMrXdp-cD5G21/RqRl<FPrs#2Z-?%mQ@q;bHgniCuh[Q8?Wk,#:A/DUP?LS]*lB"HiO^Nd/IZhscR!Rd3TZR:AoIDFZ!TA7sf/iDSIkX(IHJ*ij9Qbkd4NjpT@GmVSdl@?j2)Tu^VV6:.Y\Due!;jrXa!=1[o"p7!Dhp,RaM'DsHn++[Adf2(oM=T6;/:&O;R-C&t7M!MU]j7(1g.qL6OR,O;WWd?PJYC8Ce`I2_HY*j%ulQ[rUbh6P4Jq"-o^)m(?:Dg5#G?46<gfs/RZ'%I'n'A[pnHH#g?>#B>8`_+Xp5ce[WAW4R1=hpan[4rnX;=CnnrCXIh>[JqYujJk\[=R=fNN$Zj]\GD>4\qR*t^/R+0=4">?P1UP1tgd84Xlk,92+^d;-T_2u`m!f4"[Z?6fIM6[II]C,\Wm((m**V6P3aj)s\F^pgmdZ<FSc/&oe9=$2W;Y@i_lSeRV?%3)6W@GDoY^-M7]aqF&Z/@OBej#qDTYB9P(iih_i-+#b5$+[A[KX(F%H@?+k,."1E[q9aAnBm2?TY3n/AarPmnBZsZFJq%nBqpJ-%d_!$W'.l&fQ\XZF82ZNEU%`Z7gtA%VT?k(K9#Wa?PWS@jIti\m`5>-TF1?fKHKb-_>aL@jSo5,WQ%ZWU+9,pBLYR.m!"[k7;Qps'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!Ggp*kEH;'ZTD;qHfk\U&rrA7?Qi-j`b7Rq+qd+f"/JM0*cP<et4Rt%C7\u[2i$]VfXFTiqGS7pfM_W"*XP;Q]ok4^Tf")BOJ+=d2rI2fe!2-`@IK;6LX5^jii_Z^n+Pou:a5.aHI<O]'8b'"`6q%%TYLrjToG4Trr(+"V3c>+MaGlqo!8!rp.\lM]?QL<Y?0&$<\@E\oKFdN1;tpci^#4D9&[YpAoM=RT@I[[hpVad%Z1,c"+.k(l]?:T_Bc(_JahYcRrhcD%k,G:"\&*P)Bc[PhR?WQ3ce;_iL[P0Bj.IL6\ER5s&3l.@68n*)TcFUC&fbQREVWXg=!&7;Kd)RNYuF.!WXLieE!P:';o_o[5/+7^<:M$!"E<$8-A9FMG7Zdg`8`hZ,-NA;[0,VrnP=hke@m'kg76eNKlcl;rrE"4oWJD`UVqToYg`t#EDJ2p4$)k\5/3)&ItAtB$N+5[oW+2;a)]Ts)/]I#mn_/.E)okB5kc2Voacq/(Xk5LM]8.RepDZ\3<4_o(`XT4[&f,^/"g.n,kL6n;G/5MGA'sA-`JH!O"]2gQ\Ts.U3NR'CMb\<?<EE8@.BNB3:C+U`uk*k/ALNDJ+NrH:P?!K57i32*,6&t>ua/*!(kVIr]'oXaJ!2F!+2f,!2)2cU8(^6#4u4D[dc;o.h+8p?qFoANUb.N;2,h.HnEsQFDXe9_)fXl:BRl1hL?05f_se%2<]K&rrA0O8H/[n35>(t>Xub_$V_mDGcOCERZ2k-.8H]E7f'=ZqGbG2g`K?EHtiT\OUZg+niu3ceG(j!7%G"j]V>E+cp`5`NI4S6M`q^,hl0Vc>KG7P2?!g]ZhPT9]dppkng*Fkp#R"hJgcdsSY'j`_r4gZ8)dU+2$m5"#aL`@_n&Y5ik;M-6c-1-KYB6WH?IRH7=-;B`l-dEc+Q>*T8e2G'tu3o!*>QcEJ7W5p2Z;eV<Y!D<.+]G+^U^G8b'Pm=Y+[.(*DC<b<MQ&GrPf&r6$"I58jX7n6;CN!GLWRDY#EA>T_rBa7?DleN=l3?N=jtCE=-BEFAeH1Vfc*<R,cnrr<TNLuuBd5d3:^LU?@[0\5sF`^dO8%;=+db2'K.c9*]KIn8-KgM4kfgTuIARkZYt!.4Kj+3qPA3>iRMptOciQf;3UmNI0DD,"!:F.h:#qE?t=HIaacIh5oN=uG`7G3pHWAFeQ::<(W'p_?#a3CYV`d0%lKa)1hVjPjeO!-%r<k`K2j?9N6,!%/F=qhP1O7#EF9oE3`]K_W=^!$q.(rjp/M!23J<>URMj!;S"/J+_AWr<fEo`dkblbPk)iO8f2bS,WIT28FG]3k*--DXq;'[l4f-p2LrJ%=/8s5PZ[Q5Q,Ueq@Tnkdj8?-r,oZ4iJ__^b9D[Y"sq0J_fc3!*ThnH.O_%%^ak69WNVj'_,gpV@cI%YSj-V3nc&U'F8=F+?5N,]HiF']r'@g=FEiMgfV]>L!DDHoA<I0""8&]E7e5%>7JLMhSI`OP;99\ImRPtW#Hh:/r]?"r1fjVVKHK5;et";sluaL=&ob@1R6U6.X_A0XN%1MjR:6.5"#0`TnTDlsk0(eC$[m*7<Y3,"#Xk*p*sA*mKjoAZd#I,Set@F)7:^XQ>)U<?)mRoP5O5$_a.nY3IULa?F#@e7Tri$klWPn&Rjl3Z6rS<'4V-^_0C/TVeN>^:D07@@N9'>e&!B1>WUF1hlal2MLNL#TDi9NqF]Kp$,B3fFr+Y]CVJFn1A8>uH8Hq[T;EgA1i2,^\iTnXH[^p+p\n?i,SJ_A,`4JsZ[U8GJLM?bgJFp#)_qu=hHRWH_=cG):o7iB,/:`':_>L@^2.)(:("E>'m/I'kbDmXsMIZ/?qH)#B,18r7iX=QsB3EgB6@qYo5KD?[C/jl:h$Hrs?#o4Y5ou_:Wosn?B-<AoGSuX!EJ%UF^Y`t/YBK\4/Fn0M^KHJ^dc+8bG<ibSi-T",f"<=.qgE2/G=e!NLErc=a1']K?L[r^iS,koL@T\Y/^cD+0VGXH3g8")Qc-K%r[$1a[9:j$9LdM:KhsH.j=AWb^Okri)I8p"CJlOP$;+8_%Q=B-SGUoBiU;I]#)@5c;Yc[R#]d%22Q??V3;iAB`cBIh)Rt)FauZdk'DR#^(W'L$bU+j0ff\72@-kZ9&*eW_j8LuPraqq'km6Hg-teZ``oc605^tigVIb_p0`b6aT0Zg6Gb\;#kD?SU7jP1b&t/*]L&D"OWU@Zh&VWu^B2P7Wn8H4DH"X3n(BZ*;B$C>r&4Te%!&)p9^@p9/,?LJhZ!$I+.CaP44b$)Rd_'#J/J?!)l*p4fgP.6k;,8RC;->r6p"lNn/`l>R98QF,EhI;6]N-e'Pp<^KP,TlhUHYREhQ"0MLFb;/rrAASL2UZD0`8bj*VeOl!$bd)rHOD%%I9b`-*.FFMsVhJkI-IF(ao)_Y!.Mf[Ee\grrA1a_u@;=reC*Qh<E_RTajal.)#fQg3BCOm^Zi8IaGPS-+b8XO=)-B,OqoU7+H4'/`J03A)/-udd</-E"3a]f9'CIn2pV7>,V=HYPs,(T(p.\?gR/_Fj!n&[_+Se!V^0ur($(ALECM-)oA?Cd\SO`c2:#[/bNHg>[Q3pGUJ@r7NR7!]m&E7!;qX,J(Js1oIB[pk.ZWG62pp/$m50!?i:=h:@ku)j3'k[F?A2)U:O,K.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!.&)S!/&H[$W*T1Fj#,]!\m<S9;/H>D6\`fME,]UFp"`779<_WY*A22$;]o!I//3Yfo5jOGSTB;MR<XqpKO%+Irr=?\9so-L52R1L.=Ooc#@BTkTOPt;-"gK9HpRObin")>m!UB,]!@P*n0`:*3`fhk!"#9RrrD7Oe:6rX;?$V&Q\bYAkXF!Nn+'Ibh[3_8*=mof4(7*-,!A!'#Y!k2^@[E@NH0LdTUOoVk`A4YYP-&_e5F=+>LK[(_I_^kq@Rilqtu\Nn<nN^re+QIrr2sE8lARLrBSg#]]2`]Ff/JL/#]q^=*6!:E4NtLk."3?qH`4_!/YiZ'5B3`E]Z%sk+N$$S?Wt((a"`[5Ob(cPQ$5@8,iMg,p2WEG`ViW>t=no!$sMIBBSC^DcLp!.((W^lGd8"mNQ>6kXI(crr@_q`..D'l9G%=./s:#bJ\o&,3hDeq'nBA*5B?>2%:4'e\!hj"iP'kaUrV<G:CF;o]0EZ(!ukIpj`;D#u#@(3chA`[CY<g3"i1N!dbO3eGfO<R<XelKO%+Irr=>en<nN^re+QIrr2sE>B8lg5]RW)'KebA=H^_DRO%GZr2Dp9B#iD0^7qbp`qXFAOeq7XF5=@C,<.\J7EIF6^Pi"W,40j\C(.h91)atX/D$R;]'omoJ%Ht8X5/*3rZGWs.Id&AB<Q'=euN30Okq88YJDbsEVXp3orHsgmH;%LSXMhQP-DSs6u#ia@sV1Jr$G_qrrA`/;?$X2a[c7UIO+pnTbgT+!5HWJo&o-;T^]7mGY^n$;QMGp";-4qd9=bol;a'(Ob*k[,.O9?9`.E\!(&<5rr@P3O8)EH8,iQU/u/FHJ!.-WD;5XNnaD.=*t2nn2O\_$5*(.\Z)hV@.0TRHd#@rn^!"7UdJ,Ld7oHFs;$*gQ6/!h"rY%L/J'a+PrrCs;U](ok&qA8dW;ckTjK0cj.&?kC0Hp4LhuVi9,JMX[+k<^7'osDNN^Ar^K@&4'@IZ]jn>%M2pp3E!G<rYtro5sZ\`(8qf3SCV$($JJ!9cl$J+)r,?cE!fO`nKiYM"=B<$I"O\R_kV5j%5(dk7@(YD<$?EAd'CO?)3ZIB1KflHb'p$*%<Ihscp+[>S@Wh[R2?;qS><1"]ONIOs+0+1q"GndkG*N)ZG=RJ<!FKO%+Irr=>S[&k']QlT53pJGUjnlULqMf0h*!6Hi-mGkr@Y:I'VbC??1Z?VSNo1*ntP9+3b4a+=0f2_hN$($K5kXF!Nn+'C&nSZ)sm?>=EmQDIf2)1*"=8@Ek?i4-CnHH#*Itfd1Z["$co+0,V#E40tR5NKA1@T,:'@CE=m!ZV@Q/th_&.Ir2qXS_#TfcW?#aZ.u#5ne$b(?2a!"#!K5NkPcJ+)r,GIK,'Q`(q<GoaT#_#9p;SD26Jlp&/8G5hQB*Vri1rr<@tM*L2me:6rX;?$V&T8>er7FZhUnkt?b^\NH8f+7Cd)/&FBe8WFu3L2cW.4=S1$=ER%r($be68#&5!.U/mpe8=jrr>A<U]1=DP*BG8dfT!UGiXY=rf\>#aQj_dYe_D9m8UeDGR?YOfd-9mZ"fTi6r%t:3pf/YdJj1QQ\drj7FZhUnkoDe$(m%R!9cl$J+)r,[$8+_*+#-)(W=#rKf&64kk!%5IjB(ob/YO3EZ2<Ga#b`T*M.t12!r.'Fl`C=P?e98_o,<^>JPQ;"5(h^aS],B_F][ErTY'pfcq5X4^<IJ/ndEoen"9AUTEeXCY?lE]0gJ@S](YiUE)oXO^+g#m2G7orEI3dKMI`Vjtm\o;j)>ZkNXRnrr@_q`1QZGl9G%=./s:#cbuIJ,3hDeq'pMYUpopt\#etH8rHp#Dfj[!.rc4Fp-"JpEEpif-@R6?!213+rrBgU8,O]?,l[k<(K(24^WB<G,R6L%C@:r>C0i!s[[Jiqbcr#sJXl+81[ftkRe;Qt7uY)M:Hes3J+)r*rr<@lM#RJ=7+B!?r.!`q7sS>I^C`;\h/gE!Q9'D"D9F[iVVj33!da_Nq=q.Lr$-<h@fHF%Pb&E0J\Rn^FWN:-)'&Dj;'*_fVRMJr5iZX)(B'#^Pmqf[.D+C%TiP!LXIAfEDJt@Q/\$A*I:clg0M3gqIUHcS_qkIHr(V9l[aN!/+l)fn$:<d`)<Hq-]le]mX<VUYLUTn4Tq_girr@_m`..D(l6#cr.QJ1;RBs(BX\L<mdEl"[(A],-(JD+<`<6UBSucm&5>k(VQX<G92n/Vef2M\L/6i$&kV)^)Hq42:69_1E!.U/mpe6'(rr>ALU&P+BP,`M"Z'?5kUt`2!o1)=0eR\0pQE6ob>!rW@"<F5Dl\b]BKZD#\oHWWCp\?7&iA'jEr<W7TrVfF<R2kXbS%n6HT+Nq0[,2'orL,/\\@>li0cH3EmKqq#B"Sep?5pQ-HqC6h9kcXW,g5=+7)/sGT?pZKrrBoGi]m8OocO)/P^gP[i]m8OoagrtPnH\ak=$iFPT3S)q4k,/G+\geikXgL$M3/5rZ,eC%)[F'Co1DsJRsg)@ZA4>*I5V=J&5^T5Pbub&,Z9hTCA6CO8af\6iR)c,ug=J`\c^88P+$q8!A<\ReoMCXc1]]goN:R,!oaH!,aQ:ou1kIBX>:[nO8@%D)A7DJ1QhK!:Ohum_@^8nJD-0qM5%K8mh?eHq"&869_1E!.U0*7<7tSk]LG$.[FFf0g5qKcY]CkCHO@?:!/PC6Fln^X`qK%d;?N^U"sFL8d\7Z;uP;H(*>nr>jqS;4sL",Tc[,2!5HWGr$FTPrrA`7;#^O1a]09+@gT-WI/A<=i)fn"eTC]Qm3]'Io-&.5<[JsL\2`_ZoC/%`@.5Ej1f#(dnf=m/*kq:pr$FTPrrA`7;#^O1a]C<k''iWqPZHCB'YL`*o=EpQ<2ss%.Ua&.FDY?kl9``K]]s1)MV-kp.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.'@#`bGu/0;8Fg3Rgh^'N+g6[P/_N^l'4K01p.'Z=h:c9FPE?A+V9.3h$\7I@qJT-55tV,or_*.RdQjbWN0<>PIjrQ>;i0e)!,7a=d5l_2BV]/<h*p6IN.d8Z<`Tk?>;f:.uiCfFHM:Yrp$'[[9"]dJ`u`-(O9p`LHJG,[D&Jc4h^KkD/f`t`^%RQ@,jB[7rBh@o3\o>nQ)W-WbPW/[[&NgL>L0d)r#$Wm)V!?!+q6f4VEYDMg]YCDZY0Ja*DeP=>R(MjN(4h630u)!@237e_PPgrr>X[g?Yf@h_q6GA"$c]T.3Z.%%^fk]^am>oQ#$U\tY)BXk%D)Gah_H?en)IBsJ+Ki3nlg?;7*!0cZ\sJ3Bo1\/gPD`cup>$XXM@O&!78DD'nVMAEWV2G,JM*dpi!Hj[W^hH\Cro%*A7SaK]Xo*h^@`O:u#qU9Gg*@2H@g0_`N_jr.?<n8V('&1:OgoQuUE^1lPf-f=AcI$cZ;o^e^>$_-$EMqXHaO3S',U$G!+d&:-ODo200&Ugi?\kk->ru/[hS:uA2cEpN#a>4,:7RHdC@mt5FrDnML9."WB+]tEcM`dU)fe"1EEm[F4LVs9nZ;4NdEN^1o:r;$;DWnS^PZE_;YXmuhV;DmH,NjP.k(MB'[&2uH\5>@Y@'LKMW;*T\F@c2MgChOm+Q]o2V2Y*VG)h+=![W##NJllp?,9BgiaJ(aHh-pZ'OQk!_FZr'`A"`psekcdSX,\0=dOt_:llQ]WDmq>"Im%*#0Vl#d.*/K2g<I%0q]aeo+nqL+&s:dN9r4j![j'3U>:WZma]?7A@;/B#@Kmlu`27Fc4@['']Y4<g8uK=WAY7:5T8D1$Mj_-+_MJe6lQX>J.El1Zd<DaQd-)^-W:Le'a7Q3eq+!cGp9e,h6Zn7b7S>9oi,ZQ[Prljs/fCYH;gD*Kg#u%dS:9C)V`DBmCtCgcI?6)"oH[`.3>nNd?RqK_.ZriPi/'!,-*tkLh?s[j2*l-O],e\D(sa>79bF9#_h)8+S=p?1GW7aS"\s=.AFf*t*HHMd(qql=l6B@3V.<dA&Dr&A>;B;n^aie$QW'X>R\'o2gL/8L'BI9QrVsbHS/"(ag0?0IcR.TH:($EEDUWWI.'c9M=]@HO&!sq4ig6KV'q.#j?O95+/G)jjRr#-&UG[]YCiCqV!FRgdN`n[(5AEOa55,N1<l<J_s=(oXLWJ9nab&P3sk6PK>2>bbX<Ih>6.qeT.GeMC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!MC>,!\c2XFka/m*KEFrYNXOJb/<WSp"_B+<4dc3k=$]83mAM"kM#8W?W7^?Xg2-;p/X5!`+#nUj:`4KuIT7T"[;@6`g%9H<`f\p0XR$H8:lMn*rr=aTH77o`@V_DhqOXOX>f?04=P`fD"t([5,EI:h3o`ia[#K,#:sbNRlJDK*8aW[V0pIb/]9Rn/&-bG'ZALZ0*;0#pXD8jh^TbIg3:F#FA5NYO/HP&A,:Df7Z/QcNI:'kc3b/a>bq*U\S=R1n+6cud;/cm'mPM%m8_:.g%0^RN/bK1K4giJ#p.-!;ocP6+!6D=KMA*36:PJ3(e&Hh^>s_ZT\X"aXPKF"Pj]ghOo7/9U=so4Z[!2$+Ep;Ii=P>1,M_UGcF+@1+h1L[L+'Ru<dk,G0/$2,p,3%iaASp36\]5eKX-HFFEE=1reKXMOL>fLd8T46<N+86I.T-pok8>:\%P#`3NNV+4VbYi$2m\?Xi0GU)"#FcLN#fiWGitu>lR8UR^uR(p/Z;nR!,q,AHXimeNASf<GF]\o3<XFHF5E[Y_]$5?_t`jcM6+\hYEUX"N4-_<'e?m@+J$1)]/hA&?uqcq=#^*d^J>D2DegMMg&-[7WbiVS"G+ifBq>O;]MB%arh[m=U>K^TN*m1uO)-4N.o00lXYljj]kQ17lN5403B74[;:gq65QCcd!-Y+5=:F(!l-ekr)q;7Y)&?GWGDR3`apAn&`DP3.)kBL8%AH9:95n:!/aQ6fY2&`sC?T?,Rm:M/Mb9I?dD_UcM]eSt1?@I%,.Zt)VQt+sNH3(YGC%8k*KAKS73$>"gl-t#J:LULGWEk\f$Qg-".o#]LOH'IYPk/9'_:/;2#H<2!!O*WNnD2G0i7XH9\+=A*9c+>>()jr0.%"`OHtuLb:+EN>s/ntQlJSbiLO;)$I@[jA6LRTE/:XaXk]7P)_/ftitrM[`OolI6YglUP0kES9<f`0FWF"HE)5(#e58Su^r-/kTDfLRmCi&gTDLb)m)e(qG\m4d!h$,3&Y#,F:U/@9XJA*GdUd!$4n:Lm7;pRGi,`'sO/hC^%[X(q]qh`r"g6%'<ERqBQps5q!,&]QPHFea;o745!\sBY>B,$1q4?9[9%9Sng^JmRJ,U`uP/i^b!##bVi8af>r][`n7218#U5Aq!Y6Fq+L#(`Aq=2oun(aQ5>p&RJ]LDi#5!!?Tqih$[MlclY:7nOc4mIpo?hdp`,6%Y8*Ad]nao;@[dJj1S]>S(Jj/.=`\Nfl#4fh$9Pn/28]GLP`GDO#sa%ZL5^N+hoFFV0qnJD,ul(@_<:];u-CCp?=6f+cF"oeRVh;U*`n^B_kgn4LM+7QnT7K3?O3bSEgPQ(W@UY<XMWDN>h/&?_oGBf&FI!!^3pF#t@(J"BUmh(&qNg]nIIcUM/iop*@&#rSllAG(<pg)`#rrAZ31]I?prrC$crr<G=`*`,rVLRL65PVfQX@)9<%sjt_(]G4pLqi,n9`G+-Ee!V$J&:XD(]='mTD.bLr[s7I&Gi4jhPdU]rr@c/i\1,tdm*<VTDVt:n@Q>%rr>5DBDq^krr@tPg;H1S;"pt?_11EfG`2QKFO0jY-iX/_8,P".&V&,eRK!89jSo5>kk;7lW`2.HMXY!J?/?e*!1t8frr't=!6*@c!"6EW?h<<TJ)@e$pprVi6gBpIHD8%grYKd7^ZWX2rrBfSJ+7W1_X?q1r:oNKp[1iV/rscZqP?R9W36C)!/97g0DY.e5O[C"r*:E6]=^T4!'WGVrVMfY!/mW+`'1.spSoa[J)PTrMuJ*GchmGarr<j*r%@FMJ'X.Crr@N/rrD'Bp9>..<'BN(n6brrhBMt"T,f`erQ5'>`R4\c$bO>aoAc]thmkuH\im,^lBMm+U:_<A(O(\MkJp9r!5EQ(nT98tmdV+kq!"FFmSEg7O)#='V*j+<Y6Fq+L#(`Aq=2oun(aQ5>p&RJ]LDi#5!!?Tqih$[Mkf"E5,hBQW[ko8iHKO)rd8h6qtDK<!#J0'0(0C%c]4Fn!.O#/!9359Yn*j64mIpo?hdp`,6%Y8*Ad]nao;@[dJj1S]>S(Jj/.=`\Nfl#4fh$9Pn/28]GLP`GDO#sa%ZL5^N+hoFFV0qnJD,ul(@_<:];u-CCp?=6f+cF"oeRVh;U*`n^B_kgn4LM+7QnT7K3?O3bSEgPQ(W@UY<XMWDN>h/&?_oGBf&FI!!^3pF#t@(J"BUmh(&qNg]nIIcUM/iop*@&#rSllAG(<pg)`#rrAZ31]I?prrC$crr<G=`*`,rVLRL65PVfQX@)9<%sjt_(]G4pLqi,n9`G+-Ee!V$J&:XD(]='mTD.bLr[s7I&Gi4jhPdU]rr@c/i\1,tdm*<VTDVt:n@Q>%rr>5DBDq^krr@tPg;H1S;"pt?_11EfG`2QKFO0jY-iX/_8,P".&V&,eRK!89jSo5>kk;7lW`2.HMXY!J?/?e*!1t8frr't=!6*@c!"6EW?h<<TJ)@e$pprVi6gBpIHD8%grYKd7^ZWX2rrBfSJ+7W1_X?q1r:oNKp[1iV/rscZqP?R9W36C)!/97g0DY.e5O[C"r*:E6]=^T4!'WGVrVMfY!/mW+`'1.spSoa[J)PTrMuJ*GchmGarr<j*r%@FMJ'X.Crr@N/rrD'Bp9>..<'BN(n6brrhBMt"T,f`erQ5'>`R4\c$bO>aoAc]thmkuH\im,^lBMm+U:_<A(O(\MkJp9r!5EQ(nT98tmdV+kq!"FFmSEg7O)#='V*j+<Y6Fq+L#(`Aq=2oun(aQ5>p&RJ]LDi#5!!?Tqih$[Mkf"E5,hBQW[ko8iHKO)rd8h6qtDK<!#J0'0(0C%c]4Fn!.O#/!9359Yn*j64mIpo?hdp`,6%Y8*Ad]nao;@[dJj1S]>S(Jj/.=`\Nfl#4fh$9Pn/28]GLP`GDO#sa%ZL5^N+hoFFV0qnJD,ul(@_<:];u-CCp?=6f+cF"oeRVh;U*`n^B_kgn4LM+7QnT7K3?O3bSEgPQ(W@UY<XMWDN>h/&?_oGBf&FI!!^3pF#t@(J"BUmh(&qNg]nIIcUM/iop*@&#rSllAG(<pg)`#rrAZ31]I?prrC$crr<G=`*`,rVLRL65PVfQX@)9<%sjt_(]G4pLqi,n9`G+-Ee!V$J&:XD(]='mTD.bLr[s7I&Gi4jhPdU]rr@c/i\1,tdm*<VTDVt:n@Q>%rr>5DBDq^krr@tPg;H1S;"pt?_11EfG`2QKFO0jY-iX/_8,P".&V&,eRK!89jSo5>kk;7lW`2.HMXY!J?/?e*!1t8frr't=!6*@c!"6EW?h<<TJ)@e$pprVi6gBpIHD8%grYKd7^ZWX2rrBfSJ+7W1_X?q1r:oNKp[1iV/rscZqP?R9W36C)!/97g0DY.e5O[C"r*:E6]=^T4!'WGVrVMfY!/mW+`'1.spSoa[J)PTrMuJ*GchmGarr<j*r%@FMJ'X.Crr@N/rrD'Bp9>..<'BN(n6brrhBMt"T,f`erQ5'>`R4\c$bO>aoAc]thmkuH\im,^lBMm+U:_<A(O(\MkJp9r!5EQ(nT98tmdV+kq!"FFmSEg7O)#='V*j+<Y6Fq+L#(`Aq=2oun(aQ5>p&RJ]LDi#5!!?Tqih$[Mkf"E5,hBQW[ko8iHKO)rd8h6qtDK<!#J0'0(0C%c]4Fn!.O#/!9359Yn*j64mIpo?hdp`,6%Y8*Ad]nao;@[dJj1S]>S(Jj/.=`\Nfl#4fh$9Pn/28]GLP`GDO#sa%ZL5^N+hoFFV0qnJD,ul(@_<:];u-CCp?=6f+cF"oeRVh;U*`n^B_kgn4LM+7QnT7K3?O3bSEgPQ(W@UY<XMWDN>h/&?_oGBf&FI!!^3pF#t@(J"BUmh(&qNg]nIIcUM/iop*@&#rSllAG(<pg)`#rrAZ31]I?prrC$crr<G=`*`,rVLRL65PVfQX@)9<%sjt_(]G4pLqi,n9`G+-Ee!V$J&:XD(]='mTD.bLr[s7I&Gi4jhPdU]rr@c/i\1,tdm*<VTDVt:n@Q>%rr>5DBDq^krr@tPg;H1S;"pt?_11EfG`2QKFO0jY-iX/_8,P".&V&,eRK!89jSo5>kk;7lW`2.HMXY!J?/?e*!1t8frr't=!6*@c!"6EW?h<<TJ)@e$pprVi6gBpIHD8%grYKd7^ZWX2rrBfSJ+7W1_X?q1r:oNKp[1iV/rscZqP?R9W36C)!/97g0DY.e5O[C"r*:E6]=^T4!'WGVrVMfY!/mW+`'1.spSoa[J)PTrMuJ*GchmGarr<j*r%@FMJ'X.Crr@N/rrD'Bp9>..<'BN(n6brrhBMt"T,f`erQ5'>`R4\c$bO>aoAc]thmkuH\im,^lBMk6rY;nq^ZZ@2!0]2<!:a$<_RAs#r;qK>AmbNeMCJ,!`;<.#@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f'RU.rP`DcmShn->!2Wii)kWKl,d%q?6fujNPC:<>8<Q]*G^8Fs$4U]I!RX5bItBQi@&CU])";KYQ^arrA6<rrDRg;+E,&*n#JhJ&8Y`Qi-u8nn)8..Za@*h@fhgTMPP\bPqR];+2J*Y^8t9@K-<7gVR=i$3("IR=G"35N,gk9E'K,q(j](!#7p:Ej!7G-f(Epf`~>
endstream
endobj
16 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F2
/BaseFont /Helvetica-Bold
/Subtype /Type1
>>
endobj
17 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F3
/BaseFont /Times-Roman
/Subtype /Type1
>>
endobj
18 0 obj
<<
/Encoding /WinAnsiEncoding
/Type /Font
/Name /F1
/BaseFont /Helvetica
/Subtype /Type1
>>
endobj
19 0 obj
<<
/Length 8208
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 631.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Males\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 615.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Elevated concentrations of LH can result from) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 600.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Primary testicular failure\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 584.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Seminiferous tubule dysgenesis \050Klinefelter\222s syndrome\051\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 569.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sertoli cell failure\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 553.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Anorchia\054) Tj
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 538.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hypergonadotropic hypogonadism\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 538.38980 cm
Q
q
1 0 0 1 40 522.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Decreased in\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 507.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hypogonadism\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 491.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Gonadotropin deficiency and) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 476.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Pituitary LH deficiency\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 476.38980 cm
Q
q
1 0 0 1 40 460.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Limitation\072 ) Tj
/F1 9 Tf
(Secretion of LH is episodic\054 circadian and cyclic in nature\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 445.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 429.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Test Performed on ROCHE e411) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 414.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Remarks\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Kindly correlate clinically\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 413.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 387.88980 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
204.99350 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052END OF IMMUNOLOGY\052\052) Tj
T*
-204.99350 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 2 of 7) Tj
T*
ET
Q

endstream
endobj
20 0 obj
<<
/Length 12407
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 622.34190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 157.50000 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
0 0 0 RG
n
47.25000 5.35050 m
110.25000 5.35050 l
S
BT
1 0 0 1 0 7.03800 Tm
47.25000 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(IMMUNOLOGY) Tj
/F1 9 Tf
T*
-47.25000 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 315 -0 cm
q
1 0 0 1 0 0 cm
q
q
1 0 0 1 62 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 148 17 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
32 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
37 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
45 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
55 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
76 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
80 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
86 0 4 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
91 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
99 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
102 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
106 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
108 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
114 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
117 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
122 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
126 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
128 0 2 17 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 50.16205 -5.98880 Tm
(21252340068) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 15.54785 Tm
62 0 Td
26.79785 TL
148 0 Td
/F1 9 Tf
10.80000 TL
T*
-210 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 621.34190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 601.76190 cm
q
1 0 0 1 1 -4 cm
q
0.91125 w
0 0 0 RG
n
0 10.77854 m
239.21890 10.77854 l
S
BT
1 0 0 1 0 12.60104 Tm
14.58000 TL
/F2 9.72000 Tf
0 0 0 rg
(FSH\054 SERUM \050FOLLICLE STIMULATING HORMONE\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 577.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type \072 Serum) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 343.26190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(FSH) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(8\05658) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(mIU\057mL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 196 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 21.53800 Tm
4.98900 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Before puberty\072 0 \055 4\0560) Tj
T*
31.00950 0 Td
(mIU\057mL) Tj
T*
-35.99850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 168 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 21.53800 Tm
8.49450 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(During puberty\072 0\0563 \055) Tj
T*
17.49600 0 Td
(10\0560 mIU\057mL) Tj
T*
-25.99050 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 153.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
51.24900 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
-51.24900 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 125.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 21.53800 Tm
3.74250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Normally Menstruating) Tj
T*
27.99900 0 Td
(Females \072) Tj
T*
-31.74150 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 97.50000 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
0.97950 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Follicular Phase \072 1\0564) Tj
T*
18.01350 0 Td
(\055 9\0569 mIU\057mL) Tj
T*
-18.99300 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 69.50000 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
2.73000 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Ovulatory Peak \072 6\0562) Tj
T*
13.76100 0 Td
(\055 21\0565) Tj
( ) Tj
(mIU\057mL) Tj
T*
-16.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 41.50000 cm
q
1 0 0 1 0 -1 cm
q
BT
1 0 0 1 0 21.53800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
0.84375 w
BT
1 0 0 1 13.50000 21.53800 Tm
4.98450 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Luteal Phase \072 1\0561 \055) Tj
T*
16.75800 0 Td
(9\0562 mIU\057mL) Tj
T*
-21.74250 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 35.03800 Tm
14.99250 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Post\055menopausal) Tj
T*
-8.51850 0 Td
(Females \072 25\0568 \055 134\0568) Tj
T*
29.52450 0 Td
(mIU\057mL) Tj
T*
-35.99850 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 209.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
29.37150 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(CLIA) Tj
T*
-29.37150 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 327.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Interpretation) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 312.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(FSH promotes follicular development in the ovary and gametogenesis in the testis\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 296.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(FSH in mature females acts to stimulate development of the ovarian follicles\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 281.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Circulating FSH levels vary throughout the menstrual cycle in response to estradiol and progesterone\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 252.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 22.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(A small\054 but significant increase in circulating FSH accompanies the mid\055cycle LH surge\056 Circulating levels of FSH decline in the) Tj
T*
(luteal phase in response to estradiol and progesterone production by the developing corpus luteum\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 236.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 221.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Use\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 205.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Differential Diagnosis of gonadal disorders) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 190.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Diagnosis and management of infertility) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 190.26190 cm
Q
q
1 0 0 1 40 161.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 22.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
T*
/F2 9 Tf
(Increased In\072) Tj
T*
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 3 of 7) Tj
T*
ET
Q

endstream
endobj
21 0 obj
<<
/Length 8253
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 631.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Primary hypogonadism \050anorchia\054 testicular failure\054 menopause\051\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 615.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Gonadotropin secreting pituitary tumours\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 600.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Precocious puberty \050secondary to a CNS lesion or idiopathic\051\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 584.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Complete testicular feminization syndrome\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 569.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Luteal phase of menstrual cycle) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 569.38980 cm
Q
q
1 0 0 1 40 540.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0.84375 w
BT
1 0 0 1 0 22.53800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
T*
/F2 9 Tf
(Decreased in\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 524.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Secondary Hypogonadism\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 509.38980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Pituitary LH or FSH deficiency\054) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 493.88980 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Gonadotropin deficiency) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 493.88980 cm
Q
q
1 0 0 1 40 478.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Limitation\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 462.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Secretion of FSH is episodic\054 circadian and cyclic in nature\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 447.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Clinical evaluations may require determinations in pooled multiple serial specimens\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 431.88980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 416.38980 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Test Performed on ROCHE e411) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 400.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Remarks\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Kindly correlate clinically\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 399.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 374.38980 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
204.99350 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052END OF IMMUNOLOGY\052\052) Tj
T*
-204.99350 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 4 of 7) Tj
T*
ET
Q

endstream
endobj
22 0 obj
<<
/Length 24525
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 622.34190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 157.50000 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
0 0 0 RG
n
47.25000 5.35050 m
110.25000 5.35050 l
S
BT
1 0 0 1 0 7.03800 Tm
47.25000 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(IMMUNOLOGY) Tj
/F1 9 Tf
T*
-47.25000 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 315 -0 cm
q
1 0 0 1 0 0 cm
q
q
1 0 0 1 62 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 148 17 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
32 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
37 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
45 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
55 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
76 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
80 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
86 0 4 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
91 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
99 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
102 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
106 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
108 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
114 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
117 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
122 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
126 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
128 0 2 17 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 50.16205 -5.98880 Tm
(21252340068) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 15.54785 Tm
62 0 Td
26.79785 TL
148 0 Td
/F1 9 Tf
10.80000 TL
T*
-210 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 621.34190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 601.76190 cm
q
1 0 0 1 1 -4 cm
q
0.91125 w
0 0 0 RG
n
0 10.77854 m
256.52050 10.77854 l
S
BT
1 0 0 1 0 12.60104 Tm
14.58000 TL
/F2 9.72000 Tf
0 0 0 rg
(TESTOSTERONE TOTAL \0502ND GENERATION\051\054 SERUM) Tj
( ) Tj
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 577.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type \072 Serum) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 552.76190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(TESTOSTERONE\055TOTAL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(29\05695) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(ng\057dl) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
28.99200 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Refer Table) Tj
T*
-28.99200 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
29.37150 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(CLIA) Tj
T*
-29.37150 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 537.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Interpretation) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 521.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 319.26190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 189 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F2 11 Tf
0 0 0 rg
(Age) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 189 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F2 11 Tf
0 0 0 rg
(Reference Range Male\050ng\057dL\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 175.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
1.03125 w
BT
1 0 0 1 0 19.10200 Tm
13.52700 TL
/F2 11 Tf
0 0 0 rg
(Reference Range) Tj
T*
1 0 0 1 0 5.57500 Tm
(Female\050ng\057dL\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 162 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(Newborn\0501\05515days\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 162 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(75\055400) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 162 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(20\05564) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 148.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(1\0555 Months) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 148.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(1\055177) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 148.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(1\0555) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 135 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(6\05511 Months) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 135 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\0557) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 135 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\0555) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 121.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(Children\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 121.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 121.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 108 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(1\0555 Year) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 108 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\05525) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 108 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\05510) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 94.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(6\0559 Year) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 94.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(3\05530) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 94.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\05520) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 80.99999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F2 11 Tf
0 0 0 rg
(Puberty Tanner Stage) Tj
/F1 11 Tf
( \072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 80.99999 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 80.99999 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 67.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(1) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 67.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\05523) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 67.49999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2\05510) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 53.99999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(2) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 53.99999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(5\05570) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 53.99999 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(5\05530) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 40.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(3) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 40.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(15\055280) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 40.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(10\05530) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(4) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 27 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(105\055545) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 27 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(15\05540) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(5) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 13.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(265\055800) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 13.50000 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(10\05540) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F2 11 Tf
0 0 0 rg
(Adult) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 159.60000 -0 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(241\055827) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 319.20000 -0 cm
q
1 0 0 1 0 0 cm
q
1.03125 w
BT
1 0 0 1 0 5.60200 Tm
13.52700 TL
/F1 11 Tf
0 0 0 rg
(14\05576) Tj
T*
ET
Q
Q
q
Q
Q
q
2 J
1 j
0 0 0 RG
1 w
n
0 202.50000 m
478.80000 202.50000 l
S
n
0 0 m
0 202.50000 l
S
n
478.80000 0 m
478.80000 202.50000 l
S
n
0 0 m
478.80000 0 l
S
n
0 202.50000 m
478.80000 202.50000 l
S
n
0 175.50000 m
0 202.50000 l
S
n
478.80000 175.50000 m
478.80000 202.50000 l
S
n
0 175.50000 m
478.80000 175.50000 l
S
n
0 202.50000 m
159.60000 202.50000 l
S
n
0 175.50000 m
0 202.50000 l
S
n
159.60000 175.50000 m
159.60000 202.50000 l
S
n
0 175.50000 m
159.60000 175.50000 l
S
n
159.60000 202.50000 m
319.20000 202.50000 l
S
n
159.60000 175.50000 m
159.60000 202.50000 l
S
n
319.20000 175.50000 m
319.20000 202.50000 l
S
n
159.60000 175.50000 m
319.20000 175.50000 l
S
n
319.20000 202.50000 m
478.80000 202.50000 l
S
n
319.20000 175.50000 m
319.20000 202.50000 l
S
n
478.80000 175.50000 m
478.80000 202.50000 l
S
n
319.20000 175.50000 m
478.80000 175.50000 l
S
n
0 175.50000 m
478.80000 175.50000 l
S
n
0 162 m
0 175.50000 l
S
n
478.80000 162 m
478.80000 175.50000 l
S
n
0 162 m
478.80000 162 l
S
n
0 175.50000 m
159.60000 175.50000 l
S
n
0 162 m
0 175.50000 l
S
n
159.60000 162 m
159.60000 175.50000 l
S
n
0 162 m
159.60000 162 l
S
n
159.60000 175.50000 m
319.20000 175.50000 l
S
n
159.60000 162 m
159.60000 175.50000 l
S
n
319.20000 162 m
319.20000 175.50000 l
S
n
159.60000 162 m
319.20000 162 l
S
n
319.20000 175.50000 m
478.80000 175.50000 l
S
n
319.20000 162 m
319.20000 175.50000 l
S
n
478.80000 162 m
478.80000 175.50000 l
S
n
319.20000 162 m
478.80000 162 l
S
n
0 162 m
478.80000 162 l
S
n
0 148.50000 m
0 162 l
S
n
478.80000 148.50000 m
478.80000 162 l
S
n
0 148.50000 m
478.80000 148.50000 l
S
n
0 162 m
159.60000 162 l
S
n
0 148.50000 m
0 162 l
S
n
159.60000 148.50000 m
159.60000 162 l
S
n
0 148.50000 m
159.60000 148.50000 l
S
n
159.60000 162 m
319.20000 162 l
S
n
159.60000 148.50000 m
159.60000 162 l
S
n
319.20000 148.50000 m
319.20000 162 l
S
n
159.60000 148.50000 m
319.20000 148.50000 l
S
n
319.20000 162 m
478.80000 162 l
S
n
319.20000 148.50000 m
319.20000 162 l
S
n
478.80000 148.50000 m
478.80000 162 l
S
n
319.20000 148.50000 m
478.80000 148.50000 l
S
n
0 148.50000 m
478.80000 148.50000 l
S
n
0 135 m
0 148.50000 l
S
n
478.80000 135 m
478.80000 148.50000 l
S
n
0 135 m
478.80000 135 l
S
n
0 148.50000 m
159.60000 148.50000 l
S
n
0 135 m
0 148.50000 l
S
n
159.60000 135 m
159.60000 148.50000 l
S
n
0 135 m
159.60000 135 l
S
n
159.60000 148.50000 m
319.20000 148.50000 l
S
n
159.60000 135 m
159.60000 148.50000 l
S
n
319.20000 135 m
319.20000 148.50000 l
S
n
159.60000 135 m
319.20000 135 l
S
n
319.20000 148.50000 m
478.80000 148.50000 l
S
n
319.20000 135 m
319.20000 148.50000 l
S
n
478.80000 135 m
478.80000 148.50000 l
S
n
319.20000 135 m
478.80000 135 l
S
n
0 135 m
478.80000 135 l
S
n
0 121.50000 m
0 135 l
S
n
478.80000 121.50000 m
478.80000 135 l
S
n
0 121.50000 m
478.80000 121.50000 l
S
n
0 135 m
159.60000 135 l
S
n
0 121.50000 m
0 135 l
S
n
159.60000 121.50000 m
159.60000 135 l
S
n
0 121.50000 m
159.60000 121.50000 l
S
n
159.60000 135 m
319.20000 135 l
S
n
159.60000 121.50000 m
159.60000 135 l
S
n
319.20000 121.50000 m
319.20000 135 l
S
n
159.60000 121.50000 m
319.20000 121.50000 l
S
n
319.20000 135 m
478.80000 135 l
S
n
319.20000 121.50000 m
319.20000 135 l
S
n
478.80000 121.50000 m
478.80000 135 l
S
n
319.20000 121.50000 m
478.80000 121.50000 l
S
n
0 121.50000 m
478.80000 121.50000 l
S
n
0 108 m
0 121.50000 l
S
n
478.80000 108 m
478.80000 121.50000 l
S
n
0 108 m
478.80000 108 l
S
n
0 121.50000 m
159.60000 121.50000 l
S
n
0 108 m
0 121.50000 l
S
n
159.60000 108 m
159.60000 121.50000 l
S
n
0 108 m
159.60000 108 l
S
n
159.60000 121.50000 m
319.20000 121.50000 l
S
n
159.60000 108 m
159.60000 121.50000 l
S
n
319.20000 108 m
319.20000 121.50000 l
S
n
159.60000 108 m
319.20000 108 l
S
n
319.20000 121.50000 m
478.80000 121.50000 l
S
n
319.20000 108 m
319.20000 121.50000 l
S
n
478.80000 108 m
478.80000 121.50000 l
S
n
319.20000 108 m
478.80000 108 l
S
n
0 108 m
478.80000 108 l
S
n
0 94.49999 m
0 108 l
S
n
478.80000 94.49999 m
478.80000 108 l
S
n
0 94.49999 m
478.80000 94.49999 l
S
n
0 108 m
159.60000 108 l
S
n
0 94.49999 m
0 108 l
S
n
159.60000 94.49999 m
159.60000 108 l
S
n
0 94.49999 m
159.60000 94.49999 l
S
n
159.60000 108 m
319.20000 108 l
S
n
159.60000 94.49999 m
159.60000 108 l
S
n
319.20000 94.49999 m
319.20000 108 l
S
n
159.60000 94.49999 m
319.20000 94.49999 l
S
n
319.20000 108 m
478.80000 108 l
S
n
319.20000 94.49999 m
319.20000 108 l
S
n
478.80000 94.49999 m
478.80000 108 l
S
n
319.20000 94.49999 m
478.80000 94.49999 l
S
n
0 94.49999 m
478.80000 94.49999 l
S
n
0 80.99999 m
0 94.49999 l
S
n
478.80000 80.99999 m
478.80000 94.49999 l
S
n
0 80.99999 m
478.80000 80.99999 l
S
n
0 94.49999 m
159.60000 94.49999 l
S
n
0 80.99999 m
0 94.49999 l
S
n
159.60000 80.99999 m
159.60000 94.49999 l
S
n
0 80.99999 m
159.60000 80.99999 l
S
n
159.60000 94.49999 m
319.20000 94.49999 l
S
n
159.60000 80.99999 m
159.60000 94.49999 l
S
n
319.20000 80.99999 m
319.20000 94.49999 l
S
n
159.60000 80.99999 m
319.20000 80.99999 l
S
n
319.20000 94.49999 m
478.80000 94.49999 l
S
n
319.20000 80.99999 m
319.20000 94.49999 l
S
n
478.80000 80.99999 m
478.80000 94.49999 l
S
n
319.20000 80.99999 m
478.80000 80.99999 l
S
n
0 80.99999 m
478.80000 80.99999 l
S
n
0 67.49999 m
0 80.99999 l
S
n
478.80000 67.49999 m
478.80000 80.99999 l
S
n
0 67.49999 m
478.80000 67.49999 l
S
n
0 80.99999 m
159.60000 80.99999 l
S
n
0 67.49999 m
0 80.99999 l
S
n
159.60000 67.49999 m
159.60000 80.99999 l
S
n
0 67.49999 m
159.60000 67.49999 l
S
n
159.60000 80.99999 m
319.20000 80.99999 l
S
n
159.60000 67.49999 m
159.60000 80.99999 l
S
n
319.20000 67.49999 m
319.20000 80.99999 l
S
n
159.60000 67.49999 m
319.20000 67.49999 l
S
n
319.20000 80.99999 m
478.80000 80.99999 l
S
n
319.20000 67.49999 m
319.20000 80.99999 l
S
n
478.80000 67.49999 m
478.80000 80.99999 l
S
n
319.20000 67.49999 m
478.80000 67.49999 l
S
n
0 67.49999 m
478.80000 67.49999 l
S
n
0 54 m
0 67.49999 l
S
n
478.80000 54 m
478.80000 67.49999 l
S
n
0 54 m
478.80000 54 l
S
n
0 67.49999 m
159.60000 67.49999 l
S
n
0 54 m
0 67.49999 l
S
n
159.60000 54 m
159.60000 67.49999 l
S
n
0 54 m
159.60000 54 l
S
n
159.60000 67.49999 m
319.20000 67.49999 l
S
n
159.60000 54 m
159.60000 67.49999 l
S
n
319.20000 54 m
319.20000 67.49999 l
S
n
159.60000 54 m
319.20000 54 l
S
n
319.20000 67.49999 m
478.80000 67.49999 l
S
n
319.20000 54 m
319.20000 67.49999 l
S
n
478.80000 54 m
478.80000 67.49999 l
S
n
319.20000 54 m
478.80000 54 l
S
n
0 54 m
478.80000 54 l
S
n
0 40.50000 m
0 54 l
S
n
478.80000 40.50000 m
478.80000 54 l
S
n
0 40.50000 m
478.80000 40.50000 l
S
n
0 54 m
159.60000 54 l
S
n
0 40.50000 m
0 54 l
S
n
159.60000 40.50000 m
159.60000 54 l
S
n
0 40.50000 m
159.60000 40.50000 l
S
n
159.60000 54 m
319.20000 54 l
S
n
159.60000 40.50000 m
159.60000 54 l
S
n
319.20000 40.50000 m
319.20000 54 l
S
n
159.60000 40.50000 m
319.20000 40.50000 l
S
n
319.20000 54 m
478.80000 54 l
S
n
319.20000 40.50000 m
319.20000 54 l
S
n
478.80000 40.50000 m
478.80000 54 l
S
n
319.20000 40.50000 m
478.80000 40.50000 l
S
n
0 40.50000 m
478.80000 40.50000 l
S
n
0 27 m
0 40.50000 l
S
n
478.80000 27 m
478.80000 40.50000 l
S
n
0 27 m
478.80000 27 l
S
n
0 40.50000 m
159.60000 40.50000 l
S
n
0 27 m
0 40.50000 l
S
n
159.60000 27 m
159.60000 40.50000 l
S
n
0 27 m
159.60000 27 l
S
n
159.60000 40.50000 m
319.20000 40.50000 l
S
n
159.60000 27 m
159.60000 40.50000 l
S
n
319.20000 27 m
319.20000 40.50000 l
S
n
159.60000 27 m
319.20000 27 l
S
n
319.20000 40.50000 m
478.80000 40.50000 l
S
n
319.20000 27 m
319.20000 40.50000 l
S
n
478.80000 27 m
478.80000 40.50000 l
S
n
319.20000 27 m
478.80000 27 l
S
n
0 27 m
478.80000 27 l
S
n
0 13.50000 m
0 27 l
S
n
478.80000 13.50000 m
478.80000 27 l
S
n
0 13.50000 m
478.80000 13.50000 l
S
n
0 27 m
159.60000 27 l
S
n
0 13.50000 m
0 27 l
S
n
159.60000 13.50000 m
159.60000 27 l
S
n
0 13.50000 m
159.60000 13.50000 l
S
n
159.60000 27 m
319.20000 27 l
S
n
159.60000 13.50000 m
159.60000 27 l
S
n
319.20000 13.50000 m
319.20000 27 l
S
n
159.60000 13.50000 m
319.20000 13.50000 l
S
n
319.20000 27 m
478.80000 27 l
S
n
319.20000 13.50000 m
319.20000 27 l
S
n
478.80000 13.50000 m
478.80000 27 l
S
n
319.20000 13.50000 m
478.80000 13.50000 l
S
n
0 13.50000 m
478.80000 13.50000 l
S
n
0 0 m
0 13.50000 l
S
n
478.80000 0 m
478.80000 13.50000 l
S
n
0 0 m
478.80000 0 l
S
n
0 13.50000 m
159.60000 13.50000 l
S
n
0 0 m
0 13.50000 l
S
n
159.60000 0 m
159.60000 13.50000 l
S
n
0 0 m
159.60000 0 l
S
n
159.60000 13.50000 m
319.20000 13.50000 l
S
n
159.60000 0 m
159.60000 13.50000 l
S
n
319.20000 0 m
319.20000 13.50000 l
S
n
159.60000 0 m
319.20000 0 l
S
n
319.20000 13.50000 m
478.80000 13.50000 l
S
n
319.20000 0 m
319.20000 13.50000 l
S
n
478.80000 0 m
478.80000 13.50000 l
S
n
319.20000 0 m
478.80000 0 l
S
Q
Q
q
1 0 0 1 40 263.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 49.53800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Testosterone) Tj
/F1 9 Tf
( is the major androgenic hormone\056 It is responsible for the development of the male external genitalia and secondary) Tj
T*
(sexual characteristics\056) Tj
T*
(In females\054 its main role is as an estrogen precursor\056) Tj
T*
(In both genders\054 it also exerts anabolic effects and influences behavior\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 166.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
0 0 0 RG
n
0 88.35050 m
127.03500 88.35050 l
S
0.84375 w
0.84375 w
0.84375 w
0 0 0 RG
n
0 47.85050 m
135.03600 47.85050 l
S
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 90.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Testing is useful in males for\072) Tj
/F1 9 Tf
T*
(Evaluation of symptoms or signs of possible hypogonadism\054 delayed or precocious puberty\054) Tj
T*
(Monitoring testosterone replacement or anti\055androgen therapy\056) Tj
T*
/F2 9 Tf
(Testing is useful in females for\072) Tj
/F1 9 Tf
T*
(Evaluation of symptoms or signs of hirsutism\054 virilization\054 and oligo\055amenorrhea\054 possible testosterone deficiency\054 diagnosis of) Tj
T*
(androgen\055secreting tumors\054 evaluation of infants with ambiguous genitalia or virilization\056) Tj
T*
T*
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 5 of 7) Tj
T*
ET
Q

endstream
endobj
23 0 obj
<<
/Length 5157
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 631.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Remarks\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Kindly correlate clinically\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 615.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Correlate Clinically\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 614.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 589.38980 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
204.99350 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052END OF IMMUNOLOGY\052\052) Tj
T*
-204.99350 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 6 of 7) Tj
T*
ET
Q

endstream
endobj
24 0 obj
<<
/Length 12886
>>
stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
q
q
1 0 0 1 0 770.98050 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 68.84631 0 2.06300 cm
/FormXob.df788c331935144fa2dec278cfb8953c Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
69.29631 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 740.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 698.38980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Patient Name \072 ) Tj
/F2 9 Tf
(MISS\056 VAISHALI SONI) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Ref Doctor \072 Dr\056 SELF) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Name\072 IDR000009\055Al\055India Pathology) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 192.32670 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Age \057 Gender \072 23 years\057Female) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Client Patient ID \072 9598) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Status \072 ) Tj
/F2 9 Tf
(Final Report) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 332.67330 0 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 27 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Registered \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 13.50000 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Received \072 Aug 22\054 2025\054 07\07246 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Reported \072 Aug 23\054 2025\054 12\07255 p\056m\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 697.38980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 674.88980 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Test Description) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Value\050s\051) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Units) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
7.49100 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Biological Ref Range) Tj
T*
-7.49100 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 0 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
23.37750 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Method) Tj
T*
-23.37750 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 673.88980 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 58.51476 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 41.10000 cm
q
1 0 0 1 0 4.80000 cm
q
q
61.87500 0 0 61.87500 0 -4.80000 cm
/FormXob.5fae5878ff745fb447a825f4d49aa676 Do
Q
0.84375 w
BT
1 0 0 1 0 22.53750 Tm
61.87500 TL
61.87500 0 Td
/F1 9 Tf
10.80000 TL
T*
-61.87500 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 277.63780 41.73750 cm
q
1 0 0 1 0 -3 cm
q
q
76 0 0 45 161.63780 3 cm
/FormXob.ac84e117b0679b7b609587f5218c4125 Do
Q
0.84375 w
BT
1 0 0 1 0 21.90000 Tm
161.63780 0 Td
45 TL
76 0 Td
/F1 9 Tf
10.80000 TL
T*
-237.63780 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 0 0 cm
q
1 0 0 1 0 -4.80000 cm
q
0.65625 w
0.65625 w
0.65625 w
BT
1 0 0 1 0 31.27400 Tm
10.50000 TL
/F2 7 Tf
0 0 0 rg
(Processed at \072) Tj
/F1 7 Tf
( Diagnostica Span Pvt Ltd) Tj
T*
(IndoreNo\056 4\054 Ground Floor\054 Prakash Nagar Rd\054 Navlakha\054 Indore\054 Madhya Pradesh) Tj
T*
(452001) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 0 28.16442 cm
q
1 0 0 1 1 -1 cm
q
q
593.27560 0 0 61.66235 0 2.06300 cm
/FormXob.257654e3dc971ef0d012b196156b070d Do
Q
0.84375 w
BT
1 0 0 1 0 3.86300 Tm
62.11235 TL
593.27560 0 Td
/F1 9 Tf
10.80000 TL
T*
-593.27560 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 40 622.34190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
BT
1 0 0 1 0 7.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 157.50000 5.52393 cm
q
1 0 0 1 0 0 cm
q
0.84375 w
0 0 0 RG
n
47.25000 5.35050 m
110.25000 5.35050 l
S
BT
1 0 0 1 0 7.03800 Tm
47.25000 0 Td
13.50000 TL
/F2 9 Tf
0 0 0 rg
(IMMUNOLOGY) Tj
/F1 9 Tf
T*
-47.25000 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 315 -0 cm
q
1 0 0 1 0 0 cm
q
q
1 0 0 1 62 0 cm
q
[ ] 0 d
BT
/F3 10 Tf
12 TL
ET
1 w
0 0 0 RG
1 0 0 1 0 0 cm
0 j
BT
/F3 10 Tf
12 TL
ET
0 0 0 rg
0 J
q
1 0 0 1 0 7.54785 cm
q
1 0 0 1 0 0 cm
q
[ ] 0 d
0.00010 w
0 j
0 J
n
0 0 148 17 re
n
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
18 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
21 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
24 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
29 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
32 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
37 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
40 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
45 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
47 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
51 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
55 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
58 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
62 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
67 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
69 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
73 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
76 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
80 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
84 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
86 0 4 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
91 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
95 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
99 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
102 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
106 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
108 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
114 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
117 0 2 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
122 0 3 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
126 0 1 17 re
f*
Q
q
[ ] 0 d
0 w
0 0 0 rg
0 j
0 J
n
128 0 2 17 re
f*
Q
q
BT
/F1 7.79528 Tf
9.35433 TL
ET
BT
/F1 7.79528 Tf
9.35433 TL
ET
0 0 0 rg
BT
1 0 0 1 50.16205 -5.98880 Tm
(21252340068) Tj
T*
ET
Q
Q
Q
Q
Q
0.84375 w
BT
1 0 0 1 0 15.54785 Tm
62 0 Td
26.79785 TL
148 0 Td
/F1 9 Tf
10.80000 TL
T*
-210 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 621.34190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 601.76190 cm
q
1 0 0 1 1 -4 cm
q
0.91125 w
0 0 0 RG
n
0 10.77854 m
120.43080 10.77854 l
S
BT
1 0 0 1 0 12.60104 Tm
14.58000 TL
/F2 9.72000 Tf
0 0 0 rg
(ESTRADIOL \050E2\051 \054 SERUM) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 577.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Sample Type \072 Serum) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 458.26190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 94.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(ESTRADIOL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 94.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(47\0562) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 288.75000 94.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(pg\057mL) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 341.25000 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
0.84375 w
BT
1 0 0 1 0 102.53800 Tm
6.98250 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Menstruating females \072) Tj
T*
-1.49850 0 Td
(Follicular phase\072\055 19\0565 \055) Tj
T*
35.75700 0 Td
(144\0562) Tj
T*
-35.50950 0 Td
(Midcycle \072\055 63\0569 \055 356\0567) Tj
T*
3.74400 0 Td
(Luteal Phase \072\055 55\0568 \055) Tj
T*
31.76550 0 Td
(214\0562) Tj
T*
-40.76100 0 Td
(Post\055menopausal females) Tj
T*
10.75050 0 Td
(\050untreated\051\072\055 0 \055 32\0562) Tj
T*
-11.23050 0 Td
ET
Q
Q
q
Q
Q
q
1 0 0 1 446.25000 94.50000 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
29.37150 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(CLIA) Tj
T*
-29.37150 0 Td
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 442.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
( ) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 427.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Test Performed on Roche e411) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 411.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Interpretation) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 396.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Uses for Estradiol \050E2\051 assay\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 380.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Evaluating menstrual and fertility problems in women\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 365.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(In the evaluation of Gynecomastia or feminization states due to Estrogen producing Tumours\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 349.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Menstrual cycle irregularities\054 and sexual maturity in female patients\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 334.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Monitoring of Human Menopausal Gonadotropin \050Pergonal\051 therapy\056) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 334.26190 cm
Q
q
1 0 0 1 40 318.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Increased In\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 303.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Feminization in children) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 287.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Estrogen producing Tumours) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 272.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Gynecomastia) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 256.76190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hepatic Cirrhosis) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 241.26190 cm
q
1 0 0 1 1 -1 cm
q
BT
1 0 0 1 0 9.03800 Tm
/F1 9 Tf
10.80000 TL
0 0 0 rg
/F1 9 Tf
10.80000 TL
0 0 0 rg
<7f> Tj
ET
0.84375 w
BT
1 0 0 1 13.50000 9.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Hyperthyroidism) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 241.26190 cm
Q
q
1 0 0 1 40 225.76190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Decreased In\072) Tj
/F1 9 Tf
( Primary and Secondary Hypogonadism) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 210.26190 cm
q
1 0 0 1 1 -1 cm
q
0.84375 w
BT
1 0 0 1 0 9.03800 Tm
13.50000 TL
/F2 9 Tf
0 0 0 rg
(Limitation\072) Tj
/F1 9 Tf
( Oral contraceptives inhibit physiologic increase) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 40 194.76190 cm
0 0 0 rg
BT
/F1 10 Tf
12 TL
ET
q
1 0 0 1 0 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Remarks\072) Tj
T*
ET
Q
Q
q
Q
Q
q
1 0 0 1 210 -0 cm
q
1 0 0 1 0 -1 cm
q
0.84375 w
BT
1 0 0 1 0 8.03800 Tm
13.50000 TL
/F1 9 Tf
0 0 0 rg
(Kindly correlate clinically\056) Tj
T*
ET
Q
Q
q
Q
Q
q
Q
Q
q
1 0 0 1 40 193.76190 cm
q
1 w
1 J
0 0 0 RG
n
0 0 m
525 0 l
S
Q
Q
q
1 0 0 1 40 168.26190 cm
q
1 0 0 1 1 -11 cm
q
0.84375 w
BT
1 0 0 1 0 19.03800 Tm
204.99350 0 Td
13.50000 TL
/F1 9 Tf
0 0 0 rg
(\052\052END OF IMMUNOLOGY\052\052) Tj
T*
-204.99350 0 Td
ET
Q
Q
q
Q
Q
Q
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.40000 TL
ET
BT
/F1 9 Tf
14.40000 TL
ET
BT
1 0 0 1 519 13 Tm
(Page 7 of 7) Tj
T*
ET
Q

endstream
endobj
xref
0 25
0000000000 65535 f 
0000000009 00000 n 
0000000105 00000 n 
0000000206 00000 n 
0000000255 00000 n 
0000000701 00000 n 
0000001147 00000 n 
0000001593 00000 n 
0000002039 00000 n 
0000002485 00000 n 
0000002931 00000 n 
0000003378 00000 n 
0000016452 00000 n 
0000036925 00000 n 
0000070231 00000 n 
0000071034 00000 n 
0000090243 00000 n 
0000090356 00000 n 
0000090466 00000 n 
0000090574 00000 n 
0000098835 00000 n 
0000111296 00000 n 
0000119602 00000 n 
0000144181 00000 n 
0000149391 00000 n 
trailer
<<
/Size 25
/Root 3 0 R
/Info 2 0 R
>>
startxref
162331
%%EOF
